<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Digital Twins in Medicine - Enhanced with Visuals</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: Aptos, 'Segoe UI', sans-serif;
            background: #f5f5f5;
            padding: 40px 20px;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            background: white;
            padding: 40px;
            box-shadow: 0 0 30px rgba(0,0,0,0.1);
        }
        
        .title {
            font-size: 32px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 30px;
            text-align: center;
            border-bottom: 4px solid #1E64C8;
            padding-bottom: 20px;
        }
        
        .diagram-section {
            background: linear-gradient(135deg, #f8fbff 0%, #e8f2ff 100%);
            padding: 30px;
            border-radius: 15px;
            margin-bottom: 40px;
            border: 3px solid #1E64C8;
        }
        
        .features-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 20px;
            margin-bottom: 50px;
        }
        
        .feature-card {
            background: linear-gradient(135deg, #f8fbff 0%, #ffffff 100%);
            border: 3px solid #1E64C8;
            border-radius: 15px;
            padding: 25px;
            transition: all 0.3s;
            box-shadow: 0 4px 15px rgba(30, 100, 200, 0.1);
        }
        
        .feature-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 8px 25px rgba(30, 100, 200, 0.3);
        }
        
        .feature-title {
            font-size: 20px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 12px;
        }
        
        .feature-desc {
            font-size: 16px;
            color: #555;
            line-height: 1.6;
        }
        
        .section-divider {
            height: 4px;
            background: linear-gradient(to right, #1E64C8, #5088d4, #2874d8, #1E64C8);
            margin: 60px 0;
            border-radius: 2px;
        }
        
        .detailed-section {
            margin-bottom: 80px;
            padding: 40px;
            background: linear-gradient(135deg, #f8fbff 0%, #ffffff 100%);
            border-radius: 20px;
            border: 3px solid #e0e8f5;
            box-shadow: 0 8px 30px rgba(0, 0, 0, 0.08);
        }
        
        .section-header {
            display: flex;
            align-items: center;
            margin-bottom: 30px;
            padding-bottom: 20px;
            border-bottom: 4px solid #1E64C8;
        }
        
        .section-number {
            width: 60px;
            height: 60px;
            background: linear-gradient(135deg, #1E64C8, #2874d8);
            color: white;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 28px;
            font-weight: 700;
            margin-right: 25px;
            box-shadow: 0 6px 20px rgba(30, 100, 200, 0.4);
        }
        
        .section-title {
            font-size: 28px;
            font-weight: 700;
            color: #1E64C8;
            flex: 1;
        }
        
        .illustration-container {
            background: white;
            padding: 30px;
            border-radius: 15px;
            margin-bottom: 30px;
            border: 2px solid #e0e8f5;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.08);
        }
        
        .description-text {
            font-size: 17px;
            line-height: 1.9;
            color: #333;
            margin-bottom: 25px;
            padding: 20px;
            background: #f9f9f9;
            border-left: 5px solid #1E64C8;
            border-radius: 8px;
        }
        
        .key-points {
            background: linear-gradient(135deg, #fff8f0 0%, #ffe8cc 100%);
            padding: 30px;
            border-radius: 15px;
            border-left: 6px solid #ff9800;
            margin-bottom: 25px;
            box-shadow: 0 4px 15px rgba(255, 152, 0, 0.1);
        }
        
        .key-points h4 {
            color: #ff9800;
            font-size: 22px;
            margin-bottom: 20px;
            font-weight: 700;
        }
        
        .key-points ul {
            list-style: none;
            padding-left: 0;
        }
        
        .key-points li {
            padding: 12px 0 12px 30px;
            position: relative;
            color: #444;
            line-height: 1.7;
            font-size: 16px;
        }
        
        .key-points li:before {
            content: "▸";
            position: absolute;
            left: 0;
            color: #ff9800;
            font-weight: bold;
            font-size: 20px;
        }
        
        .example-box {
            background: linear-gradient(135deg, #f0f8f0 0%, #e0f0e0 100%);
            padding: 30px;
            border-radius: 15px;
            border-left: 6px solid #00AA00;
            box-shadow: 0 4px 15px rgba(0, 170, 0, 0.1);
        }
        
        .example-box h4 {
            color: #00AA00;
            font-size: 22px;
            margin-bottom: 15px;
            font-weight: 700;
        }
        
        .example-box p {
            color: #444;
            line-height: 1.8;
            font-size: 16px;
        }
        
        svg {
            max-width: 100%;
            height: auto;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="title">Digital Twins in Medicine</div>
        <div class="diagram-section">
            <svg width="800" height="190" viewBox="0 0 800 190">
                <!-- Real Patient -->
                <g>
                    <text x="90" y="15" text-anchor="middle" font-size="13" fill="#1E64C8" font-weight="700">Real Patient</text>
                    
                    <!-- Enhanced Patient silhouette with organs -->
                    <ellipse cx="90" cy="80" rx="65" ry="55" fill="#E8F2FF" stroke="#1E64C8" stroke-width="2.5"/>
                    
                    <!-- Human body outline -->
                    <circle cx="90" cy="55" r="12" fill="#1E64C8"/>
                    <ellipse cx="90" cy="85" rx="20" ry="28" fill="#1E64C8"/>
                    
                    <!-- Visible organ icons -->
                    <circle cx="85" cy="75" r="5" fill="#FF6B35" opacity="0.8"/> <!-- Heart -->
                    <path d="M 92 82 L 98 82 L 98 88 L 92 88 Z" fill="#00AA00" opacity="0.8"/> <!-- Liver -->
                    <ellipse cx="90" cy="95" rx="4" ry="6" fill="#CC00CC" opacity="0.8"/> <!-- Kidney -->
                    
                    <!-- Data collection with enhanced icons -->
                    <g transform="translate(30, 130)">
                        <!-- DNA icon -->
                        <rect width="25" height="18" fill="#5088d4" rx="4"/>
                        <path d="M 7 5 Q 12.5 8 18 5 M 7 13 Q 12.5 10 18 13" stroke="white" stroke-width="1.5" fill="none"/>
                        <text x="12.5" y="28" text-anchor="middle" font-size="7" fill="#5088d4" font-weight="600">DNA</text>
                    </g>
                    <g transform="translate(60, 130)">
                        <!-- EHR icon -->
                        <rect width="25" height="18" fill="#2874d8" rx="4"/>
                        <rect x="7" y="5" width="11" height="8" fill="white" rx="1"/>
                        <line x1="9" y1="7" x2="16" y2="7" stroke="#2874d8" stroke-width="1"/>
                        <line x1="9" y1="9" x2="16" y2="9" stroke="#2874d8" stroke-width="1"/>
                        <line x1="9" y1="11" x2="14" y2="11" stroke="#2874d8" stroke-width="1"/>
                        <text x="12.5" y="28" text-anchor="middle" font-size="7" fill="#2874d8" font-weight="600">EHR</text>
                    </g>
                    <g transform="translate(90, 130)">
                        <!-- Imaging icon -->
                        <rect width="25" height="18" fill="#1E64C8" rx="4"/>
                        <rect x="6" y="4" width="13" height="10" fill="white" rx="1"/>
                        <circle cx="12.5" cy="9" r="3" fill="#1E64C8"/>
                        <text x="12.5" y="28" text-anchor="middle" font-size="7" fill="#1E64C8" font-weight="600">IMG</text>
                    </g>
                    <g transform="translate(120, 130)">
                        <!-- Lab icon -->
                        <rect width="25" height="18" fill="#5088d4" rx="4"/>
                        <path d="M 10 5 L 10 10 L 8 13 L 17 13 L 15 10 L 15 5" stroke="white" stroke-width="1.5" fill="none"/>
                        <circle cx="12.5" cy="10" r="1" fill="white"/>
                        <text x="12.5" y="28" text-anchor="middle" font-size="7" fill="#5088d4" font-weight="600">LAB</text>
                    </g>
                    
                    <!-- Data streams animation lines -->
                    <path d="M 90 110 L 90 125" stroke="#1E64C8" stroke-width="2" opacity="0.6">
                        <animate attributeName="opacity" values="0.3;0.9;0.3" dur="2s" repeatCount="indefinite"/>
                    </path>
                </g>
                
                <!-- Enhanced Data flow -->
                <g>
                    <path d="M 170 80 L 230 80" stroke="#1E64C8" stroke-width="3" marker-end="url(#arrowdt)"/>
                    
                    <!-- Animated data packets -->
                    <circle cx="185" cy="80" r="3" fill="#1E64C8">
                        <animate attributeName="cx" values="170;230" dur="3s" repeatCount="indefinite"/>
                    </circle>
                    <circle cx="200" cy="80" r="3" fill="#5088d4">
                        <animate attributeName="cx" values="170;230" dur="3s" begin="1s" repeatCount="indefinite"/>
                    </circle>
                    <circle cx="215" cy="80" r="3" fill="#2874d8">
                        <animate attributeName="cx" values="170;230" dur="3s" begin="2s" repeatCount="indefinite"/>
                    </circle>
                    
                    <text x="200" y="65" text-anchor="middle" font-size="10" fill="#1E64C8" font-weight="600">Multi-omics</text>
                    <text x="200" y="100" text-anchor="middle" font-size="10" fill="#1E64C8" font-weight="600">Integration</text>
                </g>
                
                <!-- Enhanced Computational Model -->
                <g>
                    <text x="360" y="15" text-anchor="middle" font-size="13" fill="#1E64C8" font-weight="700">Computational Model</text>
                    
                    <rect x="230" y="35" width="260" height="110" fill="white" stroke="#1E64C8" stroke-width="2.5" rx="10"/>
                    
                    <!-- Hierarchical model layers with icons -->
                    <!-- Molecular layer -->
                    <g>
                        <rect x="240" y="45" width="240" height="22" fill="#E8F2FF" stroke="#1E64C8" stroke-width="1.5" rx="5"/>
                        <!-- DNA helix icon -->
                        <path d="M 250 52 Q 255 56 260 52 M 250 60 Q 255 56 260 60" stroke="#1E64C8" stroke-width="1.5" fill="none"/>
                        <text x="360" y="60" text-anchor="middle" font-size="10" fill="#1E64C8" font-weight="600">Molecular Networks</text>
                        <!-- Protein structure icon -->
                        <circle cx="455" cy="56" r="3" fill="#5088d4"/>
                        <circle cx="460" cy="58" r="3" fill="#5088d4" opacity="0.7"/>
                        <circle cx="465" cy="56" r="3" fill="#5088d4" opacity="0.5"/>
                    </g>
                    
                    <!-- Cellular layer -->
                    <g>
                        <rect x="240" y="72" width="240" height="22" fill="#E8F2FF" stroke="#1E64C8" stroke-width="1.5" rx="5"/>
                        <!-- Cell icon -->
                        <circle cx="255" cy="83" r="7" fill="none" stroke="#1E64C8" stroke-width="1.5"/>
                        <circle cx="255" cy="83" r="3" fill="#1E64C8"/>
                        <text x="360" y="87" text-anchor="middle" font-size="10" fill="#1E64C8" font-weight="600">Cellular Dynamics</text>
                        <!-- Signal pathway arrow -->
                        <path d="M 455 83 L 465 83" stroke="#5088d4" stroke-width="2" marker-end="url(#signal)"/>
                    </g>
                    
                    <!-- Organ layer -->
                    <g>
                        <rect x="240" y="99" width="240" height="22" fill="#E8F2FF" stroke="#1E64C8" stroke-width="1.5" rx="5"/>
                        <!-- Organ icon -->
                        <path d="M 250 107 Q 248 110 250 113 Q 252 115 255 113 Q 258 110 255 107 Q 252 105 250 107" fill="#CC0000" opacity="0.7"/>
                        <text x="360" y="114" text-anchor="middle" font-size="10" fill="#1E64C8" font-weight="600">Organ Function</text>
                        <!-- Graph icon -->
                        <polyline points="455,115 458,110 462,112 465,108" fill="none" stroke="#5088d4" stroke-width="1.5"/>
                    </g>
                    
                    <!-- Parameters with gauge -->
                    <g transform="translate(310, 125)">
                        <circle cx="50" cy="8" r="6" fill="none" stroke="#666" stroke-width="1"/>
                        <path d="M 50 8 L 53 5" stroke="#CC0000" stroke-width="1.5">
                            <animateTransform attributeName="transform" type="rotate" from="0 50 8" to="360 50 8" dur="4s" repeatCount="indefinite"/>
                        </path>
                        <text x="60" y="11" font-size="9" fill="#666">Personalized Parameters</text>
                    </g>
                </g>
                
                <!-- Enhanced Simulation -->
                <g>
                    <path d="M 490 85 L 550 85" stroke="#1E64C8" stroke-width="3" marker-end="url(#arrowdt)"/>
                    
                    <!-- Processing animation -->
                    <g transform="translate(515, 75)">
                        <circle cx="5" cy="5" r="8" fill="none" stroke="#1E64C8" stroke-width="2">
                            <animate attributeName="r" values="6;10;6" dur="1.5s" repeatCount="indefinite"/>
                            <animate attributeName="opacity" values="1;0.3;1" dur="1.5s" repeatCount="indefinite"/>
                        </circle>
                        <circle cx="5" cy="5" r="3" fill="#1E64C8"/>
                    </g>
                    
                    <text x="520" y="65" text-anchor="middle" font-size="10" fill="#1E64C8" font-weight="600">In Silico</text>
                    <text x="520" y="105" text-anchor="middle" font-size="10" fill="#1E64C8" font-weight="600">Simulation</text>
                </g>
                
                <!-- Enhanced Digital Twin -->
                <g>
                    <text x="680" y="15" text-anchor="middle" font-size="13" fill="#1E64C8" font-weight="700">Digital Twin</text>
                    
                    <!-- Virtual patient with digital effect -->
                    <ellipse cx="680" cy="80" rx="65" ry="55" fill="none" stroke="#1E64C8" stroke-width="2.5" stroke-dasharray="5,5">
                        <animate attributeName="stroke-dashoffset" values="0;10" dur="2s" repeatCount="indefinite"/>
                    </ellipse>
                    
                    <!-- Digital body with organs -->
                    <circle cx="680" cy="55" r="12" fill="#1E64C8" opacity="0.5"/>
                    <ellipse cx="680" cy="85" rx="20" ry="28" fill="#1E64C8" opacity="0.5"/>
                    
                    <!-- Digital organ representations -->
                    <circle cx="675" cy="75" r="5" fill="#FF6B35" opacity="0.6">
                        <animate attributeName="r" values="5;6;5" dur="1s" repeatCount="indefinite"/>
                    </circle>
                    <rect x="682" y="82" width="6" height="6" fill="#00AA00" opacity="0.6">
                        <animate attributeName="opacity" values="0.6;0.9;0.6" dur="1.2s" repeatCount="indefinite"/>
                    </rect>
                    <ellipse cx="680" cy="95" rx="4" ry="6" fill="#CC00CC" opacity="0.6">
                        <animate attributeName="ry" values="6;7;6" dur="1.4s" repeatCount="indefinite"/>
                    </ellipse>
                    
                    <!-- Digital grid overlay -->
                    <g opacity="0.3">
                        <line x1="640" y1="50" x2="640" y2="110" stroke="#1E64C8" stroke-width="0.5"/>
                        <line x1="660" y1="50" x2="660" y2="110" stroke="#1E64C8" stroke-width="0.5"/>
                        <line x1="700" y1="50" x2="700" y2="110" stroke="#1E64C8" stroke-width="0.5"/>
                        <line x1="720" y1="50" x2="720" y2="110" stroke="#1E64C8" stroke-width="0.5"/>
                        <line x1="640" y1="60" x2="720" y2="60" stroke="#1E64C8" stroke-width="0.5"/>
                        <line x1="640" y1="80" x2="720" y2="80" stroke="#1E64C8" stroke-width="0.5"/>
                        <line x1="640" y1="100" x2="720" y2="100" stroke="#1E64C8" stroke-width="0.5"/>
                    </g>
                    
                    <!-- Prediction outputs with icons -->
                    <g transform="translate(620, 130)">
                        <rect width="35" height="18" fill="#2874d8" rx="4"/>
                        <path d="M 10 9 L 13 12 L 18 7" stroke="white" stroke-width="1.5" fill="none"/>
                        <text x="17.5" y="28" text-anchor="middle" font-size="7" fill="#2874d8" font-weight="600">Response</text>
                    </g>
                    <g transform="translate(660, 130)">
                        <rect width="35" height="18" fill="#1E64C8" rx="4"/>
                        <circle cx="17.5" cy="9" r="5" fill="none" stroke="white" stroke-width="1.5"/>
                        <path d="M 17.5 6 L 17.5 9 L 20 11" stroke="white" stroke-width="1.5" fill="none"/>
                        <text x="17.5" y="28" text-anchor="middle" font-size="7" fill="#1E64C8" font-weight="600">Outcome</text>
                    </g>
                    <g transform="translate(700, 130)">
                        <rect width="35" height="18" fill="#5088d4" rx="4"/>
                        <path d="M 10 12 L 15 7 L 18 10 L 22 6 L 25 9" stroke="white" stroke-width="1.5" fill="none"/>
                        <text x="17.5" y="28" text-anchor="middle" font-size="7" fill="#5088d4" font-weight="600">Risk</text>
                    </g>
                </g>
                
                <!-- Enhanced Feedback loop -->
                <g>
                    <path d="M 680 155 Q 680 175 360 175 Q 90 175 90 155" stroke="#CC0000" stroke-width="2.5" stroke-dasharray="5,3" fill="none" marker-end="url(#arrowfb)">
                        <animate attributeName="stroke-dashoffset" values="0;-8" dur="1s" repeatCount="indefinite"/>
                    </path>
                    <text x="360" y="187" text-anchor="middle" font-size="10" fill="#CC0000" font-weight="600">Continuous Learning & Validation</text>
                </g>
                
                <!-- Enhanced Treatment scenarios -->
                <g>
                    <rect x="495" y="25" width="100" height="45" fill="#fff4e6" stroke="#1E64C8" stroke-width="2" stroke-dasharray="3,3" rx="5"/>
                    <text x="545" y="38" text-anchor="middle" font-size="9" fill="#1E64C8" font-weight="700">Test Scenarios:</text>
                    <g transform="translate(505, 42)">
                        <circle cx="5" cy="5" r="3" fill="#00AA00"/>
                        <text x="10" y="8" font-size="8" fill="#666">Drug A vs B</text>
                    </g>
                    <g transform="translate(505, 52)">
                        <circle cx="5" cy="5" r="3" fill="#0088CC"/>
                        <text x="10" y="8" font-size="8" fill="#666">Dose optimization</text>
                    </g>
                    <g transform="translate(505, 62)">
                        <circle cx="5" cy="5" r="3" fill="#CC00CC"/>
                        <text x="10" y="8" font-size="8" fill="#666">Time scheduling</text>
                    </g>
                </g>
                
                <!-- Arrow markers -->
                <defs>
                    <marker id="arrowdt" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto" markerUnits="strokeWidth">
                        <path d="M0,0 L0,6 L9,3 z" fill="#1E64C8"/>
                    </marker>
                    <marker id="arrowfb" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto" markerUnits="strokeWidth">
                        <path d="M0,0 L0,6 L9,3 z" fill="#CC0000"/>
                    </marker>
                    <marker id="signal" markerWidth="6" markerHeight="6" refX="5" refY="3" orient="auto" markerUnits="strokeWidth">
                        <path d="M0,0 L0,6 L6,3 z" fill="#5088d4"/>
                    </marker>
                </defs>
            </svg>
        </div>
        
        
        <div class="features-grid">
            <div class="feature-card">
                <div class="feature-title">1. Patient Models</div>
                <div class="feature-desc">Computational patient representations across multiple biological scales</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">2. Simulation Frameworks</div>
                <div class="feature-desc">In silico clinical trials for virtual drug testing</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">3. Parameter Estimation</div>
                <div class="feature-desc">Personalizing model parameters from patient data</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">4. Treatment Optimization</div>
                <div class="feature-desc">Simulating and optimizing treatment strategies</div>
            </div>
        
            <div class="feature-card">
                <div class="feature-title">5. Validation Approaches</div>
                <div class="feature-desc">Comparing predictions to real-world outcomes</div>
            </div>
        </div>

        <div class="section-divider"></div>

        <!-- SECTION 1: Patient Models -->
        <div class="detailed-section">
            <div class="section-header">
                <div class="section-number">1</div>
                <div class="section-title">Patient Models: Computational Patient Representations</div>
            </div>
            
            <div class="illustration-container">
                <svg width="1100" height="320" viewBox="0 0 1100 320">
                    <text x="550" y="30" text-anchor="middle" font-size="22" fill="#1E64C8" font-weight="700">Multi-Scale Patient Modeling Framework</text>
                    
                    <!-- Molecular Level -->
                    <g>
                        <rect x="20" y="60" width="250" height="240" fill="#f0f8ff" stroke="#1E64C8" stroke-width="3" rx="10"/>
                        <text x="145" y="90" text-anchor="middle" font-size="16" fill="#1E64C8" font-weight="700">Molecular Level</text>
                        
                        <!-- DNA Double Helix -->
                        <g transform="translate(60, 110)">
                            <path d="M 20 10 Q 45 5 70 10 Q 95 15 120 10 Q 145 5 170 10" stroke="#9C27B0" stroke-width="4" fill="none"/>
                            <path d="M 20 50 Q 45 55 70 50 Q 95 45 120 50 Q 145 55 170 50" stroke="#9C27B0" stroke-width="4" fill="none"/>
                            
                            <line x1="35" y1="12" x2="35" y2="48" stroke="#666" stroke-width="2.5"/>
                            <line x1="70" y1="10" x2="70" y2="50" stroke="#666" stroke-width="2.5"/>
                            <line x1="105" y1="12" x2="105" y2="48" stroke="#666" stroke-width="2.5"/>
                            <line x1="140" y1="10" x2="140" y2="50" stroke="#666" stroke-width="2.5"/>
                            
                            <circle cx="35" cy="12" r="4" fill="#FF6B35"/>
                            <circle cx="35" cy="48" r="4" fill="#00AA00"/>
                            <circle cx="70" cy="10" r="4" fill="#0088CC"/>
                            <circle cx="70" cy="50" r="4" fill="#FFD700"/>
                            <circle cx="105" cy="12" r="4" fill="#FF6B35"/>
                            <circle cx="105" cy="48" r="4" fill="#00AA00"/>
                            <circle cx="140" cy="10" r="4" fill="#0088CC"/>
                            <circle cx="140" cy="48" r="4" fill="#FFD700"/>
                        </g>
                        
                        <text x="145" y="185" text-anchor="middle" font-size="13" fill="#333" font-weight="600">Data Types:</text>
                        <text x="145" y="205" text-anchor="middle" font-size="12" fill="#555">• Genomics & DNA sequencing</text>
                        <text x="145" y="222" text-anchor="middle" font-size="12" fill="#555">• Proteomics & protein networks</text>
                        <text x="145" y="239" text-anchor="middle" font-size="12" fill="#555">• Metabolomics & pathways</text>
                        <text x="145" y="256" text-anchor="middle" font-size="12" fill="#555">• Gene expression profiles</text>
                        <text x="145" y="273" text-anchor="middle" font-size="12" fill="#555">• Epigenetic modifications</text>
                    </g>
                    
                    <!-- Arrow 1 -->
                    <path d="M 280 180 L 310 180" stroke="#1E64C8" stroke-width="4" marker-end="url(#arrow1)"/>
                    <text x="295" y="170" text-anchor="middle" font-size="11" fill="#1E64C8" font-weight="600">Scale Up</text>
                    
                    <!-- Cellular Level -->
                    <g>
                        <rect x="320" y="60" width="250" height="240" fill="#f0fff0" stroke="#00AA00" stroke-width="3" rx="10"/>
                        <text x="445" y="90" text-anchor="middle" font-size="16" fill="#00AA00" font-weight="700">Cellular Level</text>
                        
                        <!-- Detailed Cell -->
                        <g transform="translate(445, 145)">
                            <ellipse cx="0" cy="0" rx="50" ry="45" fill="none" stroke="#00AA00" stroke-width="3"/>
                            
                            <!-- Nucleus -->
                            <circle cx="0" cy="0" r="18" fill="#FF6B35" opacity="0.6"/>
                            <circle cx="0" cy="0" r="12" fill="#CC0000" opacity="0.8"/>
                            
                            <!-- Mitochondria -->
                            <ellipse cx="-25" cy="-15" rx="10" ry="7" fill="#0088CC" opacity="0.7"/>
                            <path d="M -30 -15 L -20 -15 M -30 -13 L -20 -13 M -30 -17 L -20 -17" stroke="white" stroke-width="1"/>
                            
                            <ellipse cx="25" cy="15" rx="10" ry="7" fill="#0088CC" opacity="0.7"/>
                            <path d="M 20 15 L 30 15 M 20 13 L 30 13 M 20 17 L 30 17" stroke="white" stroke-width="1"/>
                            
                            <!-- Endoplasmic Reticulum -->
                            <path d="M -35 10 Q -30 15 -25 10 Q -20 5 -15 10" stroke="#9C27B0" stroke-width="2" fill="none" opacity="0.7"/>
                            <path d="M -35 20 Q -30 25 -25 20 Q -20 15 -15 20" stroke="#9C27B0" stroke-width="2" fill="none" opacity="0.7"/>
                            
                            <!-- Golgi Apparatus -->
                            <g transform="translate(15, -20)">
                                <path d="M 0 0 Q 5 2 10 0" stroke="#FFD700" stroke-width="2" fill="none" opacity="0.7"/>
                                <path d="M 0 4 Q 5 6 10 4" stroke="#FFD700" stroke-width="2" fill="none" opacity="0.7"/>
                                <path d="M 0 8 Q 5 10 10 8" stroke="#FFD700" stroke-width="2" fill="none" opacity="0.7"/>
                            </g>
                        </g>
                        
                        <text x="445" y="220" text-anchor="middle" font-size="13" fill="#333" font-weight="600">Processes:</text>
                        <text x="445" y="240" text-anchor="middle" font-size="12" fill="#555">• Cell signaling & communication</text>
                        <text x="445" y="257" text-anchor="middle" font-size="12" fill="#555">• Cell cycle & division</text>
                        <text x="445" y="274" text-anchor="middle" font-size="12" fill="#555">• Apoptosis & cell death</text>
                        <text x="445" y="291" text-anchor="middle" font-size="12" fill="#555">• Metabolism & energy production</text>
                    </g>
                    
                    <!-- Arrow 2 -->
                    <path d="M 580 180 L 610 180" stroke="#1E64C8" stroke-width="4" marker-end="url(#arrow1)"/>
                    <text x="595" y="170" text-anchor="middle" font-size="11" fill="#1E64C8" font-weight="600">Scale Up</text>
                    
                    <!-- Organ Level -->
                    <g>
                        <rect x="620" y="60" width="250" height="240" fill="#fff8f0" stroke="#FF9800" stroke-width="3" rx="10"/>
                        <text x="745" y="90" text-anchor="middle" font-size="16" fill="#FF9800" font-weight="700">Organ Level</text>
                        
                        <!-- Detailed Heart -->
                        <g transform="translate(745, 150)">
                            <!-- Heart shape -->
                            <path d="M 0 10 C -20 -10 -40 -10 -40 10 C -40 25 -25 40 0 55 C 25 40 40 25 40 10 C 40 -10 20 -10 0 10" fill="#FF6B35" opacity="0.8" stroke="#CC0000" stroke-width="2"/>
                            
                            <!-- Heart chambers -->
                            <ellipse cx="-15" cy="15" rx="10" ry="12" fill="#CC0000" opacity="0.5"/>
                            <ellipse cx="15" cy="15" rx="10" ry="12" fill="#CC0000" opacity="0.5"/>
                            
                            <!-- Blood vessels -->
                            <path d="M -20 -5 Q -25 -10 -30 -15" stroke="#CC0000" stroke-width="3" fill="none"/>
                            <path d="M 0 -5 Q 0 -12 0 -18" stroke="#0088CC" stroke-width="3" fill="none"/>
                            <path d="M 20 -5 Q 25 -10 30 -15" stroke="#CC0000" stroke-width="3" fill="none"/>
                            
                            <!-- Pulse wave -->
                            <circle cx="0" cy="20" r="25" fill="none" stroke="#FF6B35" stroke-width="2" opacity="0.3">
                                <animate attributeName="r" values="25;35;25" dur="1s" repeatCount="indefinite"/>
                                <animate attributeName="opacity" values="0.3;0;0.3" dur="1s" repeatCount="indefinite"/>
                            </circle>
                        </g>
                        
                        <text x="745" y="225" text-anchor="middle" font-size="13" fill="#333" font-weight="600">Functions:</text>
                        <text x="745" y="245" text-anchor="middle" font-size="12" fill="#555">• Cardiac hemodynamics</text>
                        <text x="745" y="262" text-anchor="middle" font-size="12" fill="#555">• Tissue perfusion & oxygenation</text>
                        <text x="745" y="279" text-anchor="middle" font-size="12" fill="#555">• Organ-organ interactions</text>
                        <text x="745" y="296" text-anchor="middle" font-size="12" fill="#555">• Mechanical & electrical activity</text>
                    </g>
                    
                    <!-- Arrow 3 -->
                    <path d="M 880 180 L 910 180" stroke="#1E64C8" stroke-width="4" marker-end="url(#arrow1)"/>
                    <text x="895" y="170" text-anchor="middle" font-size="11" fill="#1E64C8" font-weight="600">Integrate</text>
                    
                    <!-- System Level -->
                    <g>
                        <rect x="920" y="60" width="160" height="240" fill="#f8f0ff" stroke="#9C27B0" stroke-width="3" rx="10"/>
                        <text x="1000" y="85" text-anchor="middle" font-size="15" fill="#9C27B0" font-weight="700">Whole Body</text>
                        <text x="1000" y="102" text-anchor="middle" font-size="15" fill="#9C27B0" font-weight="700">System</text>
                        
                        <!-- Full body representation -->
                        <g transform="translate(1000, 170)">
                            <circle cx="0" cy="-40" r="15" fill="#1E64C8" opacity="0.7"/>
                            <ellipse cx="0" cy="-10" rx="22" ry="30" fill="#1E64C8" opacity="0.7"/>
                            
                            <!-- Organs overlay -->
                            <circle cx="-5" cy="-15" r="6" fill="#FF6B35" opacity="0.8"/>
                            <rect x="3" y="-20" width="8" height="12" fill="#00AA00" opacity="0.8"/>
                            <ellipse cx="0" cy="5" rx="5" ry="8" fill="#FFD700" opacity="0.8"/>
                            
                            <!-- Arms -->
                            <line x1="-22" y1="-5" x2="-35" y2="10" stroke="#1E64C8" stroke-width="5" opacity="0.7"/>
                            <line x1="22" y1="-5" x2="35" y2="10" stroke="#1E64C8" stroke-width="5" opacity="0.7"/>
                            
                            <!-- Legs -->
                            <line x1="-8" y1="20" x2="-12" y2="45" stroke="#1E64C8" stroke-width="5" opacity="0.7"/>
                            <line x1="8" y1="20" x2="12" y2="45" stroke="#1E64C8" stroke-width="5" opacity="0.7"/>
                        </g>
                        
                        <text x="1000" y="250" text-anchor="middle" font-size="12" fill="#555">• Homeostasis</text>
                        <text x="1000" y="267" text-anchor="middle" font-size="12" fill="#555">• Multi-organ</text>
                        <text x="1000" y="284" text-anchor="middle" font-size="12" fill="#555">• Systemic physiology</text>
                    </g>
                    
                    <defs>
                        <marker id="arrow1" markerWidth="12" markerHeight="12" refX="10" refY="4" orient="auto">
                            <path d="M0,0 L0,8 L12,4 z" fill="#1E64C8"/>
                        </marker>
                    </defs>
                </svg>
            </div>
            
            <div class="description-text">
                Patient models form the foundation of digital twin technology by creating computational representations that capture the biological complexity of individual patients across multiple scales. These models integrate diverse data sources including genomics, proteomics, imaging, and clinical parameters to construct a comprehensive digital representation of patient physiology and pathology. The multi-scale approach enables understanding of how molecular changes propagate through cellular, tissue, and organ levels to manifest as clinical symptoms.
            </div>
            
            <div class="key-points">
                <h4>Key Components</h4>
                <ul>
                    <li><strong>Multi-scale Integration:</strong> Models span from molecular interactions at the gene and protein level through cellular processes and organ function to whole-body physiology, capturing the hierarchical nature of biological systems</li>
                    <li><strong>Mathematical Frameworks:</strong> Utilize ordinary differential equations (ODEs) for temporal dynamics, partial differential equations (PDEs) for spatial distributions, agent-based models for cellular interactions, and machine learning for pattern recognition</li>
                    <li><strong>Data Assimilation:</strong> Continuously integrate patient-specific data including electronic health records, laboratory results, medical imaging (CT, MRI, PET), genomic sequencing, and wearable sensor data</li>
                    <li><strong>Dynamic Representation:</strong> Capture temporal evolution of disease states, treatment responses, and physiological changes over multiple time scales from seconds (heartbeat) to years (aging, disease progression)</li>
                    <li><strong>Uncertainty Quantification:</strong> Explicitly model biological variability and measurement uncertainty to provide confidence intervals on predictions</li>
                </ul>
            </div>
            
            <div class="example-box">
                <h4>Clinical Example: Cardiovascular Digital Twin</h4>
                <p>
                    A cardiac digital twin for a 65-year-old patient with heart failure combines CT/MRI imaging to create a patient-specific 3D heart geometry showing chamber dimensions and wall thickness. ECG data calibrates electrical conduction parameters, while blood biomarkers (BNP, troponin) inform metabolic state. Genetic variants in ion channel genes (SCN5A, KCNH2) personalize electrophysiology parameters. The model successfully predicts ejection fraction changes with beta-blockers (predicted: 38% → 45%, observed: 37% → 46%), simulates stress test responses to guide safe exercise limits, and identifies optimal cardiac resynchronization therapy pacing parameters, reducing hospitalizations by 60% over 12 months.
                </p>
            </div>
        </div>

        <!-- SECTION 2: Simulation Frameworks -->
        <div class="detailed-section">
            <div class="section-header">
                <div class="section-number">2</div>
                <div class="section-title">Simulation Frameworks: In Silico Clinical Trials</div>
            </div>
            
            <div class="illustration-container">
                <svg width="1100" height="380" viewBox="0 0 1100 380">
                    <text x="550" y="30" text-anchor="middle" font-size="22" fill="#1E64C8" font-weight="700">Virtual Clinical Trial Pipeline</text>
                    
                    <!-- Step 1: Virtual Population -->
                    <g>
                        <rect x="20" y="60" width="200" height="280" fill="#f0f8ff" stroke="#1E64C8" stroke-width="3" rx="10"/>
                        <text x="120" y="85" text-anchor="middle" font-size="15" fill="#1E64C8" font-weight="700">Virtual Population</text>
                        
                        <!-- Multiple diverse patient avatars -->
                        <g transform="translate(30, 100)">
                            <circle cx="30" cy="20" r="12" fill="#5088d4"/>
                            <ellipse cx="30" cy="42" rx="14" ry="18" fill="#5088d4"/>
                            <text x="30" y="70" text-anchor="middle" font-size="9" fill="#333">Male, 45</text>
                        </g>
                        
                        <g transform="translate(85, 100)">
                            <circle cx="30" cy="20" r="12" fill="#FF69B4"/>
                            <ellipse cx="30" cy="42" rx="14" ry="18" fill="#FF69B4"/>
                            <text x="30" y="70" text-anchor="middle" font-size="9" fill="#333">Female, 62</text>
                        </g>
                        
                        <g transform="translate(140, 100)">
                            <circle cx="30" cy="20" r="12" fill="#2874d8"/>
                            <ellipse cx="30" cy="42" rx="14" ry="18" fill="#2874d8"/>
                            <text x="30" y="70" text-anchor="middle" font-size="9" fill="#333">Male, 58</text>
                        </g>
                        
                        <g transform="translate(30, 175)">
                            <circle cx="30" cy="20" r="12" fill="#FF1493"/>
                            <ellipse cx="30" cy="42" rx="14" ry="18" fill="#FF1493"/>
                            <text x="30" y="70" text-anchor="middle" font-size="9" fill="#333">Female, 39</text>
                        </g>
                        
                        <g transform="translate(85, 175)">
                            <circle cx="30" cy="20" r="12" fill="#1E64C8"/>
                            <ellipse cx="30" cy="42" rx="14" ry="18" fill="#1E64C8"/>
                            <text x="30" y="70" text-anchor="middle" font-size="9" fill="#333">Male, 71</text>
                        </g>
                        
                        <g transform="translate(140, 175)">
                            <circle cx="30" cy="20" r="12" fill="#FF6B9D"/>
                            <ellipse cx="30" cy="42" rx="14" ry="18" fill="#FF6B9D"/>
                            <text x="30" y="70" text-anchor="middle" font-size="9" fill="#333">Female, 54</text>
                        </g>
                        
                        <text x="120" y="270" text-anchor="middle" font-size="13" fill="#333" font-weight="600">n = 10,000+ patients</text>
                        <rect x="35" y="280" width="170" height="50" fill="#e8f2ff" rx="5"/>
                        <text x="120" y="298" text-anchor="middle" font-size="11" fill="#333">Demographics: Age, Gender</text>
                        <text x="120" y="312" text-anchor="middle" font-size="11" fill="#333">Comorbidities: Diabetes, HTN</text>
                        <text x="120" y="326" text-anchor="middle" font-size="11" fill="#333">Disease Severity: Stage I-IV</text>
                    </g>
                    
                    <!-- Arrow -->
                    <path d="M 230 200 L 260 200" stroke="#1E64C8" stroke-width="4" marker-end="url(#arrow2)"/>
                    <text x="245" y="190" text-anchor="middle" font-size="12" fill="#1E64C8" font-weight="600">Randomize</text>
                    
                    <!-- Step 2: Treatment Arms -->
                    <g>
                        <rect x="270" y="60" width="220" height="280" fill="#f0fff0" stroke="#00AA00" stroke-width="3" rx="10"/>
                        <text x="380" y="85" text-anchor="middle" font-size="15" fill="#00AA00" font-weight="700">Treatment Arms</text>
                        
                        <!-- Arm A -->
                        <rect x="285" y="100" width="190" height="70" fill="#e8ffe8" stroke="#00AA00" stroke-width="2" rx="8"/>
                        <text x="380" y="120" text-anchor="middle" font-size="13" fill="#00AA00" font-weight="700">Treatment A (Experimental)</text>
                        <text x="380" y="138" text-anchor="middle" font-size="11" fill="#333">Drug X @ 100mg twice daily</text>
                        <text x="380" y="153" text-anchor="middle" font-size="10" fill="#555">Duration: 12 weeks</text>
                        <text x="380" y="166" text-anchor="middle" font-size="10" fill="#555">n = 5,000 virtual patients</text>
                        
                        <!-- Arm B -->
                        <rect x="285" y="180" width="190" height="70" fill="#fff8e8" stroke="#FF9800" stroke-width="2" rx="8"/>
                        <text x="380" y="200" text-anchor="middle" font-size="13" fill="#FF9800" font-weight="700">Treatment B (Combination)</text>
                        <text x="380" y="218" text-anchor="middle" font-size="11" fill="#333">Drug X + Drug Y combo</text>
                        <text x="380" y="233" text-anchor="middle" font-size="10" fill="#555">Duration: 12 weeks</text>
                        <text x="380" y="246" text-anchor="middle" font-size="10" fill="#555">n = 3,000 virtual patients</text>
                        
                        <!-- Control -->
                        <rect x="285" y="260" width="190" height="70" fill="#f0f0f0" stroke="#666" stroke-width="2" rx="8"/>
                        <text x="380" y="280" text-anchor="middle" font-size="13" fill="#666" font-weight="700">Control (Placebo)</text>
                        <text x="380" y="298" text-anchor="middle" font-size="11" fill="#333">Standard of care only</text>
                        <text x="380" y="313" text-anchor="middle" font-size="10" fill="#555">Duration: 12 weeks</text>
                        <text x="380" y="326" text-anchor="middle" font-size="10" fill="#555">n = 2,000 virtual patients</text>
                    </g>
                    
                    <!-- Arrow -->
                    <path d="M 500 200 L 530 200" stroke="#1E64C8" stroke-width="4" marker-end="url(#arrow2)"/>
                    <text x="515" y="190" text-anchor="middle" font-size="12" fill="#1E64C8" font-weight="600">Simulate</text>
                    
                    <!-- Step 3: Parallel Computing -->
                    <g>
                        <rect x="540" y="60" width="200" height="280" fill="#fff8f0" stroke="#FF9800" stroke-width="3" rx="10"/>
                        <text x="640" y="85" text-anchor="middle" font-size="15" fill="#FF9800" font-weight="700">Parallel Computing</text>
                        
                        <!-- Computer clusters -->
                        <g transform="translate(560, 100)">
                            <rect x="0" y="0" width="70" height="50" fill="#1E64C8" rx="5"/>
                            <rect x="5" y="5" width="60" height="40" fill="#fff" rx="3"/>
                            <line x1="15" y1="15" x2="55" y2="15" stroke="#1E64C8" stroke-width="3"/>
                            <line x1="15" y1="23" x2="55" y2="23" stroke="#1E64C8" stroke-width="3"/>
                            <line x1="15" y1="31" x2="45" y2="31" stroke="#1E64C8" stroke-width="3"/>
                            <text x="35" y="65" text-anchor="middle" font-size="10" fill="#333">Cluster 1</text>
                            <circle cx="60" cy="10" r="4" fill="#00FF00">
                                <animate attributeName="opacity" values="1;0.3;1" dur="1s" repeatCount="indefinite"/>
                            </circle>
                        </g>
                        
                        <g transform="translate(650, 100)">
                            <rect x="0" y="0" width="70" height="50" fill="#2874d8" rx="5"/>
                            <rect x="5" y="5" width="60" height="40" fill="#fff" rx="3"/>
                            <line x1="15" y1="15" x2="55" y2="15" stroke="#2874d8" stroke-width="3"/>
                            <line x1="15" y1="23" x2="55" y2="23" stroke="#2874d8" stroke-width="3"/>
                            <line x1="15" y1="31" x2="45" y2="31" stroke="#2874d8" stroke-width="3"/>
                            <text x="35" y="65" text-anchor="middle" font-size="10" fill="#333">Cluster 2</text>
                            <circle cx="60" cy="10" r="4" fill="#00FF00">
                                <animate attributeName="opacity" values="1;0.3;1" dur="1s" begin="0.3s" repeatCount="indefinite"/>
                            </circle>
                        </g>
                        
                        <g transform="translate(560, 175)">
                            <rect x="0" y="0" width="70" height="50" fill="#5088d4" rx="5"/>
                            <rect x="5" y="5" width="60" height="40" fill="#fff" rx="3"/>
                            <line x1="15" y1="15" x2="55" y2="15" stroke="#5088d4" stroke-width="3"/>
                            <line x1="15" y1="23" x2="55" y2="23" stroke="#5088d4" stroke-width="3"/>
                            <line x1="15" y1="31" x2="45" y2="31" stroke="#5088d4" stroke-width="3"/>
                            <text x="35" y="65" text-anchor="middle" font-size="10" fill="#333">Cluster 3</text>
                            <circle cx="60" cy="10" r="4" fill="#00FF00">
                                <animate attributeName="opacity" values="1;0.3;1" dur="1s" begin="0.6s" repeatCount="indefinite"/>
                            </circle>
                        </g>
                        
                        <g transform="translate(650, 175)">
                            <rect x="0" y="0" width="70" height="50" fill="#1E64C8" rx="5"/>
                            <rect x="5" y="5" width="60" height="40" fill="#fff" rx="3"/>
                            <line x1="15" y1="15" x2="55" y2="15" stroke="#1E64C8" stroke-width="3"/>
                            <line x1="15" y1="23" x2="55" y2="23" stroke="#1E64C8" stroke-width="3"/>
                            <line x1="15" y1="31" x2="45" y2="31" stroke="#1E64C8" stroke-width="3"/>
                            <text x="35" y="65" text-anchor="middle" font-size="10" fill="#333">Cluster 4</text>
                            <circle cx="60" cy="10" r="4" fill="#00FF00">
                                <animate attributeName="opacity" values="1;0.3;1" dur="1s" begin="0.9s" repeatCount="indefinite"/>
                            </circle>
                        </g>
                        
                        <text x="640" y="265" text-anchor="middle" font-size="12" fill="#333" font-weight="600">Time Evolution</text>
                        <text x="640" y="283" text-anchor="middle" font-size="11" fill="#555">Week 0 → Week 12</text>
                        <rect x="560" y="295" width="160" height="35" fill="#ffe8e8" rx="5"/>
                        <text x="640" y="312" text-anchor="middle" font-size="11" fill="#CC0000" font-weight="600">Monte Carlo: 1000 runs</text>
                        <text x="640" y="326" text-anchor="middle" font-size="10" fill="#555">per patient scenario</text>
                    </g>
                    
                    <!-- Arrow -->
                    <path d="M 750 200 L 780 200" stroke="#1E64C8" stroke-width="4" marker-end="url(#arrow2)"/>
                    <text x="765" y="190" text-anchor="middle" font-size="12" fill="#1E64C8" font-weight="600">Analyze</text>
                    
                    <!-- Step 4: Results -->
                    <g>
                        <rect x="790" y="60" width="290" height="280" fill="#f8f0ff" stroke="#9C27B0" stroke-width="3" rx="10"/>
                        <text x="935" y="85" text-anchor="middle" font-size="15" fill="#9C27B0" font-weight="700">Trial Results & Statistics</text>
                        
                        <!-- Efficacy Chart -->
                        <rect x="810" y="100" width="250" height="90" fill="#fff" stroke="#666" stroke-width="2" rx="5"/>
                        <text x="935" y="118" text-anchor="middle" font-size="12" fill="#333" font-weight="600">Primary Endpoint: Tumor Reduction</text>
                        
                        <!-- Bar chart -->
                        <rect x="830" y="155" width="40" height="25" fill="#00AA00"/>
                        <text x="850" y="172" text-anchor="middle" font-size="10" fill="#fff" font-weight="600">78%</text>
                        <text x="850" y="188" text-anchor="middle" font-size="9" fill="#333">Arm A</text>
                        
                        <rect x="890" y="145" width="40" height="35" fill="#FF9800"/>
                        <text x="910" y="167" text-anchor="middle" font-size="10" fill="#fff" font-weight="600">85%</text>
                        <text x="910" y="188" text-anchor="middle" font-size="9" fill="#333">Arm B</text>
                        
                        <rect x="950" y="165" width="40" height="15" fill="#666"/>
                        <text x="970" y="177" text-anchor="middle" font-size="10" fill="#fff" font-weight="600">32%</text>
                        <text x="970" y="188" text-anchor="middle" font-size="9" fill="#333">Control</text>
                        
                        <line x1="820" y1="180" x2="1000" y2="180" stroke="#333" stroke-width="1.5"/>
                        
                        <!-- Safety Profile -->
                        <rect x="810" y="200" width="250" height="50" fill="#ffe8e8" stroke="#CC0000" stroke-width="2" rx="5"/>
                        <text x="935" y="218" text-anchor="middle" font-size="12" fill="#CC0000" font-weight="600">Safety Profile</text>
                        <text x="935" y="233" text-anchor="middle" font-size="10" fill="#333">Grade 3+ AEs: Arm A (5%), Arm B (12%)</text>
                        <text x="935" y="246" text-anchor="middle" font-size="10" fill="#333">Discontinuation: Arm A (3%), Arm B (8%)</text>
                        
                        <!-- Statistical Significance -->
                        <rect x="810" y="260" width="250" height="70" fill="#e8ffe8" stroke="#00AA00" stroke-width="2" rx="5"/>
                        <text x="935" y="278" text-anchor="middle" font-size="12" fill="#00AA00" font-weight="600">Statistical Analysis</text>
                        <text x="935" y="295" text-anchor="middle" font-size="10" fill="#333">Arm B vs Control: p < 0.001</text>
                        <text x="935" y="308" text-anchor="middle" font-size="10" fill="#333">Hazard Ratio: 0.42 (95% CI: 0.35-0.51)</text>
                        <text x="935" y="321" text-anchor="middle" font-size="10" fill="#333">Number Needed to Treat: 2.8</text>
                    </g>
                    
                    <!-- Bottom annotation -->
                    <text x="550" y="365" text-anchor="middle" font-size="11" fill="#666" font-style="italic">Computational time: 48 hours vs 2-3 years for traditional clinical trial</text>
                    
                    <defs>
                        <marker id="arrow2" markerWidth="12" markerHeight="12" refX="10" refY="4" orient="auto">
                            <path d="M0,0 L0,8 L12,4 z" fill="#1E64C8"/>
                        </marker>
                    </defs>
                </svg>
            </div>
            
            <div class="description-text">
                In silico clinical trials leverage computational simulation frameworks to conduct virtual studies that complement or reduce the need for traditional clinical trials. These frameworks enable researchers to test hypotheses, optimize trial designs, identify optimal patient populations, and predict treatment outcomes before conducting expensive and time-consuming real-world trials. By simulating thousands of virtual patients, researchers can rapidly explore multiple treatment strategies and identify the most promising approaches for further development.
            </div>
            
            <div class="key-points">
                <h4>Key Advantages</h4>
                <ul>
                    <li><strong>Accelerated Development:</strong> Rapidly test multiple treatment strategies, doses, combinations, and schedules simultaneously without patient safety concerns, reducing development time from years to weeks</li>
                    <li><strong>Cost Reduction:</strong> Dramatically reduce trial costs (up to 90%) by identifying failed approaches early and optimizing trial parameters before real patient enrollment, saving millions in development costs</li>
                    <li><strong>Ethical Benefits:</strong> Minimize patient exposure to potentially ineffective or harmful treatments through virtual screening, protecting vulnerable populations from unnecessary risk</li>
                    <li><strong>Rare Disease Research:</strong> Enable trials for conditions where patient recruitment is challenging by generating synthetic cohorts that match real population statistics</li>
                    <li><strong>Regulatory Insights:</strong> Provide supporting evidence for regulatory submissions (FDA, EMA) and help design more informative and efficient clinical trials</li>
                    <li><strong>Dose Optimization:</strong> Identify optimal dosing regimens and treatment schedules before human trials, maximizing efficacy while minimizing toxicity</li>
                </ul>
            </div>
            
            <div class="example-box">
                <h4>Clinical Example: Oncology Drug Development</h4>
                <p>
                    A pharmaceutical company developing a novel cancer immunotherapy uses in silico trials to test the drug across 10,000 virtual patients with varying tumor genetics (KRAS, BRAF, TP53 mutations), immune profiles (PD-L1 expression, tumor infiltrating lymphocytes), and disease stages (I-IV). The simulation identifies that the drug is most effective in patients with high PD-L1 expression (>50%) combined with specific genetic mutations. This enables the company to design a biomarker-enriched Phase II trial enrolling only likely responders, reducing trial size from 500 to 150 patients while increasing success probability from 30% to 65%. The virtual trial also identifies an optimal dosing schedule (10mg/kg Q3W) that balances efficacy and immune-related adverse events, and predicts a median overall survival benefit of 8.4 months vs control, which is subsequently confirmed in the real trial (observed: 8.1 months, 95% CI: 6.8-9.7).
                </p>
            </div>
        </div>

        <!-- SECTION 3: Parameter Estimation -->
        <div class="detailed-section">
            <div class="section-header">
                <div class="section-number">3</div>
                <div class="section-title">Parameter Estimation: Personalizing Model Parameters</div>
            </div>
            
            <div class="illustration-container">
                <svg width="1100" height="400" viewBox="0 0 1100 400">
                    <text x="550" y="30" text-anchor="middle" font-size="22" fill="#1E64C8" font-weight="700">Parameter Estimation & Model Calibration Workflow</text>
                    
                    <!-- Patient Data Collection -->
                    <g>
                        <rect x="20" y="60" width="220" height="300" fill="#f0f8ff" stroke="#1E64C8" stroke-width="3" rx="10"/>
                        <text x="130" y="85" text-anchor="middle" font-size="15" fill="#1E64C8" font-weight="700">Patient Data Collection</text>
                        
                        <!-- Clinical Measurements -->
                        <g transform="translate(40, 100)">
                            <rect width="180" height="45" fill="#e8f2ff" stroke="#FF6B35" stroke-width="2" rx="6"/>
                            <circle cx="20" cy="22.5" r="10" fill="#FF6B35"/>
                            <path d="M 20 17 L 20 22.5 L 25 25" stroke="white" stroke-width="2" fill="none"/>
                            <text x="45" y="18" font-size="12" fill="#333" font-weight="600">Clinical Measurements</text>
                            <text x="45" y="33" font-size="10" fill="#555">BP: 145/92 mmHg</text>
                            <text x="45" y="44" font-size="10" fill="#555">HR: 88 bpm, Temp: 37.2°C</text>
                        </g>
                        
                        <!-- Lab Values -->
                        <g transform="translate(40, 155)">
                            <rect width="180" height="45" fill="#e8f2ff" stroke="#0088CC" stroke-width="2" rx="6"/>
                            <path d="M 15 17 L 15 27 L 12 32 L 28 32 L 25 27 L 25 17" stroke="#0088CC" stroke-width="2" fill="none"/>
                            <circle cx="20" cy="24" r="2" fill="#0088CC"/>
                            <text x="45" y="18" font-size="12" fill="#333" font-weight="600">Laboratory Results</text>
                            <text x="45" y="33" font-size="10" fill="#555">Glucose: 186 mg/dL</text>
                            <text x="45" y="44" font-size="10" fill="#555">HbA1c: 8.2%, Cr: 1.1 mg/dL</text>
                        </g>
                        
                        <!-- Imaging Data -->
                        <g transform="translate(40, 210)">
                            <rect width="180" height="45" fill="#e8f2ff" stroke="#9C27B0" stroke-width="2" rx="6"/>
                            <rect x="12" y="14" width="18" height="22" fill="#9C27B0" opacity="0.3" rx="2"/>
                            <circle cx="21" cy="25" r="5" fill="#9C27B0"/>
                            <text x="45" y="18" font-size="12" fill="#333" font-weight="600">Medical Imaging</text>
                            <text x="45" y="33" font-size="10" fill="#555">MRI: Tumor vol. 42.3 cm³</text>
                            <text x="45" y="44" font-size="10" fill="#555">CT: Lesion density 45 HU</text>
                        </g>
                        
                        <!-- Time Series -->
                        <g transform="translate(40, 265)">
                            <rect width="180" height="45" fill="#e8f2ff" stroke="#00AA00" stroke-width="2" rx="6"/>
                            <path d="M 14 20 L 14 32 L 16 28 L 19 30 L 22 24 L 25 27 L 28 22" stroke="#00AA00" stroke-width="2" fill="none"/>
                            <text x="45" y="18" font-size="12" fill="#333" font-weight="600">Continuous Monitoring</text>
                            <text x="45" y="33" font-size="10" fill="#555">CGM: 7-day glucose profile</text>
                            <text x="45" y="44" font-size="10" fill="#555">Activity: 8,500 steps/day avg</text>
                        </g>
                        
                        <text x="130" y="340" text-anchor="middle" font-size="11" fill="#666" font-style="italic">Real-time & Historical Data</text>
                    </g>
                    
                    <!-- Arrow -->
                    <path d="M 250 210 L 280 210" stroke="#1E64C8" stroke-width="4" marker-end="url(#arrow3)"/>
                    
                    <!-- Model Structure -->
                    <g>
                        <rect x="290" y="60" width="220" height="300" fill="#fff8f0" stroke="#FF9800" stroke-width="3" rx="10"/>
                        <text x="400" y="85" text-anchor="middle" font-size="15" fill="#FF9800" font-weight="700">Computational Model</text>
                        
                        <!-- Compartment Model -->
                        <g transform="translate(310, 110)">
                            <rect x="0" y="0" width="80" height="60" fill="#ffe8cc" stroke="#FF9800" stroke-width="2.5" rx="6"/>
                            <text x="40" y="25" text-anchor="middle" font-size="12" fill="#333" font-weight="600">Drug</text>
                            <text x="40" y="40" text-anchor="middle" font-size="11" fill="#333">Compartment</text>
                            <text x="40" y="52" text-anchor="middle" font-size="9" fill="#555">C(t)</text>
                            
                            <path d="M 85 30 L 110 30" stroke="#666" stroke-width="2.5" marker-end="url(#arrow3)"/>
                            <text x="97" y="24" text-anchor="middle" font-size="10" fill="#CC0000">k₁</text>
                            
                            <rect x="115" y="0" width="80" height="60" fill="#ffe8cc" stroke="#FF9800" stroke-width="2.5" rx="6"/>
                            <text x="155" y="25" text-anchor="middle" font-size="12" fill="#333" font-weight="600">Effect</text>
                            <text x="155" y="40" text-anchor="middle" font-size="11" fill="#333">Site</text>
                            <text x="155" y="52" text-anchor="middle" font-size="9" fill="#555">E(t)</text>
                        </g>
                        
                        <!-- Differential Equations -->
                        <rect x="310" y="190" width="180" height="50" fill="#fff" stroke="#666" stroke-width="2" rx="5"/>
                        <text x="400" y="208" text-anchor="middle" font-size="12" fill="#333" font-weight="600">Mathematical Model</text>
                        <text x="400" y="225" text-anchor="middle" font-size="11" fill="#333" font-style="italic">dC/dt = -k₁·C + k₂·I(t)</text>
                        <text x="400" y="237" text-anchor="middle" font-size="11" fill="#333" font-style="italic">dE/dt = k₃·C - k₄·E</text>
                        
                        <!-- Unknown Parameters Box -->
                        <rect x="310" y="255" width="180" height="95" fill="#ffcccc" stroke="#CC0000" stroke-width="3" stroke-dasharray="5,3" rx="8"/>
                        <text x="400" y="275" text-anchor="middle" font-size="13" fill="#CC0000" font-weight="700">Unknown Parameters</text>
                        <text x="400" y="295" text-anchor="middle" font-size="11" fill="#555">θ₁ = k₁ (clearance rate)</text>
                        <text x="400" y="310" text-anchor="middle" font-size="11" fill="#555">θ₂ = k₂ (absorption rate)</text>
                        <text x="400" y="325" text-anchor="middle" font-size="11" fill="#555">θ₃ = EC₅₀ (potency)</text>
                        <text x="400" y="340" text-anchor="middle" font-size="11" fill="#555">θ₄ = Eₘₐₓ (max effect)</text>
                    </g>
                    
                    <!-- Arrow -->
                    <path d="M 520 210 L 550 210" stroke="#1E64C8" stroke-width="4" marker-end="url(#arrow3)"/>
                    
                    <!-- Optimization Algorithm -->
                    <g>
                        <rect x="560" y="60" width="220" height="300" fill="#f0fff0" stroke="#00AA00" stroke-width="3" rx="10"/>
                        <text x="670" y="85" text-anchor="middle" font-size="15" fill="#00AA00" font-weight="700">Optimization Engine</text>
                        
                        <!-- Step 1: Initialize -->
                        <rect x="580" y="100" width="180" height="45" fill="#e8ffe8" stroke="#00AA00" stroke-width="2" rx="6"/>
                        <circle cx="600" cy="122.5" r="12" fill="#00AA00" opacity="0.3"/>
                        <text x="625" y="118" font-size="12" fill="#333" font-weight="600">1. Initialize Parameters</text>
                        <text x="625" y="133" font-size="10" fill="#555">θ⁰ = [θ₁⁰, θ₂⁰, θ₃⁰, θ₄⁰]</text>
                        
                        <path d="M 670 150 L 670 163" stroke="#00AA00" stroke-width="3" marker-end="url(#arrow3)"/>
                        
                        <!-- Step 2: Simulate -->
                        <rect x="580" y="168" width="180" height="45" fill="#ccf0cc" stroke="#00AA00" stroke-width="2" rx="6"/>
                        <circle cx="600" cy="190.5" r="12" fill="#00AA00" opacity="0.5"/>
                        <text x="625" y="186" font-size="12" fill="#333" font-weight="600">2. Run Simulation</text>
                        <text x="625" y="201" font-size="10" fill="#555">ŷ = f(θⁱ, x, t)</text>
                        
                        <path d="M 670 218 L 670 231" stroke="#00AA00" stroke-width="3" marker-end="url(#arrow3)"/>
                        
                        <!-- Step 3: Compare -->
                        <rect x="580" y="236" width="180" height="45" fill="#b3e6b3" stroke="#00AA00" stroke-width="2" rx="6"/>
                        <circle cx="600" cy="258.5" r="12" fill="#00AA00" opacity="0.7"/>
                        <text x="625" y="254" font-size="12" fill="#333" font-weight="600">3. Compute Error</text>
                        <text x="625" y="269" font-size="10" fill="#555">J(θ) = Σ(yᵢ - ŷᵢ)²</text>
                        
                        <!-- Iteration Loop -->
                        <path d="M 765 258 Q 790 210 765 162" stroke="#FF9800" stroke-width="3" stroke-dasharray="5,3" fill="none" marker-end="url(#arrow3)"/>
                        <text x="800" y="200" font-size="11" fill="#FF9800" font-weight="600">Update θ</text>
                        <text x="800" y="215" font-size="9" fill="#666">Gradient</text>
                        <text x="800" y="226" font-size="9" fill="#666">Descent</text>
                        
                        <!-- Convergence Check -->
                        <rect x="580" y="295" width="180" height="55" fill="#e8ffe8" stroke="#9C27B0" stroke-width="2" rx="6"/>
                        <text x="670" y="313" text-anchor="middle" font-size="12" fill="#9C27B0" font-weight="600">Convergence Check</text>
                        <text x="670" y="329" text-anchor="middle" font-size="10" fill="#555">|θⁱ⁺¹ - θⁱ| < ε</text>
                        <text x="670" y="343" text-anchor="middle" font-size="9" fill="#666">tolerance: ε = 10⁻⁶</text>
                    </g>
                    
                    <!-- Arrow -->
                    <path d="M 790 210 L 820 210" stroke="#1E64C8" stroke-width="4" marker-end="url(#arrow3)"/>
                    
                    <!-- Calibrated Model -->
                    <g>
                        <rect x="830" y="60" width="250" height="300" fill="#f8f0ff" stroke="#9C27B0" stroke-width="3" rx="10"/>
                        <text x="955" y="85" text-anchor="middle" font-size="15" fill="#9C27B0" font-weight="700">Personalized Model</text>
                        
                        <!-- Optimal Parameters -->
                        <rect x="850" y="100" width="210" height="60" fill="#e8d4ff" stroke="#9C27B0" stroke-width="2" rx="6"/>
                        <text x="955" y="118" text-anchor="middle" font-size="13" fill="#333" font-weight="600">Optimized Parameters</text>
                        <text x="955" y="135" text-anchor="middle" font-size="11" fill="#555">θ* = [0.42, 1.87, 3.21, 95.3]</text>
                        <text x="955" y="150" text-anchor="middle" font-size="10" fill="#666">Converged after 247 iterations</text>
                        
                        <!-- Uncertainty -->
                        <rect x="850" y="170" width="210" height="70" fill="#f0e8ff" stroke="#9C27B0" stroke-width="2" rx="6"/>
                        <text x="955" y="188" text-anchor="middle" font-size="13" fill="#333" font-weight="600">Uncertainty Bounds</text>
                        <text x="955" y="205" text-anchor="middle" font-size="10" fill="#555">95% CI θ₁: [0.38, 0.46]</text>
                        <text x="955" y="220" text-anchor="middle" font-size="10" fill="#555">95% CI θ₂: [1.72, 2.03]</text>
                        <text x="955" y="235" text-anchor="middle" font-size="10" fill="#555">Covariance matrix computed</text>
                        
                        <!-- Goodness of Fit -->
                        <rect x="850" y="250" width="210" height="60" fill="#dcd0ff" stroke="#9C27B0" stroke-width="2" rx="6"/>
                        <text x="955" y="268" text-anchor="middle" font-size="13" fill="#333" font-weight="600">Model Fit Quality</text>
                        <text x="955" y="285" text-anchor="middle" font-size="11" fill="#555">R² = 0.94 (excellent fit)</text>
                        <text x="955" y="300" text-anchor="middle" font-size="11" fill="#555">RMSE = 2.1 units</text>
                        
                        <!-- Validation -->
                        <rect x="850" y="320" width="210" height="30" fill="#ccf0cc" stroke="#00AA00" stroke-width="2" rx="6"/>
                        <path d="M 895 335 L 900 340 L 910 330" stroke="#00AA00" stroke-width="3" fill="none"/>
                        <text x="955" y="340" text-anchor="middle" font-size="12" fill="#00AA00" font-weight="600">✓ Validated on holdout data</text>
                    </g>
                    
                    <!-- Bottom timeline -->
                    <text x="550" y="385" text-anchor="middle" font-size="11" fill="#666" font-style="italic">Typical computation time: 30 minutes to 2 hours depending on model complexity</text>
                    
                    <defs>
                        <marker id="arrow3" markerWidth="12" markerHeight="12" refX="10" refY="4" orient="auto">
                            <path d="M0,0 L0,8 L12,4 z" fill="#1E64C8"/>
                        </marker>
                    </defs>
                </svg>
            </div>
            
            <div class="description-text">
                Parameter estimation is the critical process of calibrating computational models to match individual patient characteristics and responses. This personalization transforms generic models into patient-specific digital twins by determining the optimal parameter values that best reproduce observed clinical data. The process involves sophisticated mathematical optimization and statistical methods including maximum likelihood estimation, Bayesian inference, and nonlinear least squares to ensure model accuracy and quantify uncertainty in parameter estimates.
            </div>
            
            <div class="key-points">
                <h4>Key Methods & Techniques</h4>
                <ul>
                    <li><strong>Maximum Likelihood Estimation (MLE):</strong> Finds parameters that maximize the probability of observing the measured data given the model, assuming a specific error distribution (typically Gaussian)</li>
                    <li><strong>Bayesian Inference:</strong> Incorporates prior knowledge about parameter ranges and quantifies parameter uncertainty through posterior probability distributions using Markov Chain Monte Carlo (MCMC) sampling</li>
                    <li><strong>Optimization Algorithms:</strong> Employs gradient descent (Levenberg-Marquardt), genetic algorithms, particle swarm optimization, simulated annealing, or ensemble Kalman filters to efficiently search high-dimensional parameter spaces</li>
                    <li><strong>Identifiability Analysis:</strong> Determines which parameters can be reliably estimated from available data using sensitivity analysis, Fisher Information Matrix, and profile likelihood methods</li>
                    <li><strong>Sensitivity Analysis:</strong> Assesses how parameter uncertainty propagates to model predictions, guiding data collection priorities and identifying which measurements are most informative</li>
                    <li><strong>Cross-Validation:</strong> Uses k-fold or leave-one-out cross-validation to prevent overfitting and ensure parameter estimates generalize to new data</li>
                </ul>
            </div>
            
            <div class="example-box">
                <h4>Clinical Example: Diabetes Management Personalization</h4>
                <p>
                    For a 54-year-old Type 2 diabetes patient with BMI 32 kg/m², parameter estimation uses 14 days of continuous glucose monitoring data (CGM), detailed insulin dosing history (long-acting insulin glargine 28 units daily, rapid-acting insulin aspart with meals), meal logs with carbohydrate counting, and exercise records from wearable devices. The optimization algorithm calibrates a glucose-insulin dynamics model, determining patient-specific parameters: insulin sensitivity (SI = 0.00042 L/mU/min, 30% below population average), glucose effectiveness (SG = 0.021 min⁻¹), basal glucose production (EGP₀ = 2.1 mg/kg/min), and insulin clearance rate (k = 0.15 min⁻¹). These calibrated parameters enable accurate prediction of glucose responses to meals and insulin with RMSE of 12 mg/dL. The personalized model supports optimized dosing strategies including adjusted carbohydrate ratios (1:12g instead of standard 1:15g) and correction factors, reducing hypoglycemic events below 70 mg/dL by 45% (from 3.2 to 1.8 events/week) and improving time-in-range 70-180 mg/dL from 62% to 78% over 3 months.
                </p>
            </div>
        </div>

        <!-- SECTION 4: Treatment Optimization -->
        <div class="detailed-section">
            <div class="section-header">
                <div class="section-number">4</div>
                <div class="section-title">Treatment Optimization: Simulating Treatment Strategies</div>
            </div>
            
            <div class="illustration-container">
                <svg width="1100" height="420" viewBox="0 0 1100 420">
                    <text x="550" y="30" text-anchor="middle" font-size="22" fill="#1E64C8" font-weight="700">Multi-Objective Treatment Optimization Framework</text>
                    
                    <!-- Patient Digital Twin -->
                    <g>
                        <rect x="20" y="60" width="180" height="320" fill="#f0f8ff" stroke="#1E64C8" stroke-width="3" rx="10"/>
                        <text x="110" y="85" text-anchor="middle" font-size="15" fill="#1E64C8" font-weight="700">Patient Digital Twin</text>
                        
                        <!-- Patient Avatar -->
                        <g transform="translate(110, 130)">
                            <ellipse cx="0" cy="0" rx="50" ry="45" fill="none" stroke="#1E64C8" stroke-width="3" stroke-dasharray="5,3">
                                <animate attributeName="stroke-dashoffset" values="0;8" dur="1.5s" repeatCount="indefinite"/>
                            </ellipse>
                            <circle cx="0" cy="-15" r="12" fill="#1E64C8" opacity="0.7"/>
                            <ellipse cx="0" cy="10" rx="17" ry="25" fill="#1E64C8" opacity="0.7"/>
                            
                            <!-- Tumor -->
                            <circle cx="-8" cy="5" r="8" fill="#CC0000" opacity="0.8"/>
                            <text x="-8" y="8" text-anchor="middle" font-size="6" fill="#fff" font-weight="600">T</text>
                        </g>
                        
                        <!-- Current State -->
                        <rect x="35" y="200" width="150" height="85" fill="#ffe8e8" stroke="#CC0000" stroke-width="2" rx="6"/>
                        <text x="110" y="218" text-anchor="middle" font-size="12" fill="#CC0000" font-weight="600">Current State</text>
                        <text x="110" y="235" text-anchor="middle" font-size="10" fill="#555">Tumor: 4.2 cm diameter</text>
                        <text x="110" y="250" text-anchor="middle" font-size="10" fill="#555">PSA: 45 ng/mL</text>
                        <text x="110" y="265" text-anchor="middle" font-size="10" fill="#555">Performance: ECOG 1</text>
                        <text x="110" y="280" text-anchor="middle" font-size="10" fill="#555">QoL Score: 62/100</text>
                        
                        <!-- Constraints -->
                        <rect x="35" y="295" width="150" height="75" fill="#fff8e8" stroke="#FF9800" stroke-width="2" rx="6"/>
                        <text x="110" y="313" text-anchor="middle" font-size="12" fill="#FF9800" font-weight="600">Constraints</text>
                        <text x="110" y="330" text-anchor="middle" font-size="9" fill="#555">Age: 67 years</text>
                        <text x="110" y="343" text-anchor="middle" font-size="9" fill="#555">Comorbid: CHF (NYHA II)</text>
                        <text x="110" y="356" text-anchor="middle" font-size="9" fill="#555">Max toxicity: Grade 2</text>
                        <text x="110" y="369" text-anchor="middle" font-size="9" fill="#555">Budget: $150K/year limit</text>
                    </g>
                    
                    <!-- Arrow -->
                    <path d="M 210 220 L 240 220" stroke="#1E64C8" stroke-width="4" marker-end="url(#arrow4)"/>
                    
                    <!-- Treatment Options -->
                    <g>
                        <rect x="250" y="60" width="230" height="320" fill="#f0fff0" stroke="#00AA00" stroke-width="3" rx="10"/>
                        <text x="365" y="85" text-anchor="middle" font-size="15" fill="#00AA00" font-weight="700">Treatment Options</text>
                        
                        <!-- Option 1 -->
                        <rect x="265" y="100" width="200" height="62" fill="#e8ffe8" stroke="#00AA00" stroke-width="2" rx="6"/>
                        <circle cx="280" cy="131" r="8" fill="#00AA00"/>
                        <text x="280" y="135" text-anchor="middle" font-size="11" fill="#fff" font-weight="600">1</text>
                        <text x="365" y="118" text-anchor="middle" font-size="12" fill="#333" font-weight="600">Chemotherapy Alone</text>
                        <text x="365" y="134" text-anchor="middle" font-size="10" fill="#555">Docetaxel 75 mg/m²</text>
                        <text x="365" y="148" text-anchor="middle" font-size="9" fill="#555">Q3W × 6 cycles (18 weeks)</text>
                        
                        <!-- Option 2 -->
                        <rect x="265" y="172" width="200" height="62" fill="#e8f8ff" stroke="#0088CC" stroke-width="2" rx="6"/>
                        <circle cx="280" cy="203" r="8" fill="#0088CC"/>
                        <text x="280" y="207" text-anchor="middle" font-size="11" fill="#fff" font-weight="600">2</text>
                        <text x="365" y="190" text-anchor="middle" font-size="12" fill="#333" font-weight="600">Hormone Therapy</text>
                        <text x="365" y="206" text-anchor="middle" font-size="10" fill="#555">Enzalutamide 160 mg PO daily</text>
                        <text x="365" y="220" text-anchor="middle" font-size="9" fill="#555">Continuous until progression</text>
                        
                        <!-- Option 3 -->
                        <rect x="265" y="244" width="200" height="62" fill="#fff0f8" stroke="#CC00CC" stroke-width="2" rx="6"/>
                        <circle cx="280" cy="275" r="8" fill="#CC00CC"/>
                        <text x="280" y="279" text-anchor="middle" font-size="11" fill="#fff" font-weight="600">3</text>
                        <text x="365" y="262" text-anchor="middle" font-size="12" fill="#333" font-weight="600">Combination Therapy</text>
                        <text x="365" y="278" text-anchor="middle" font-size="10" fill="#555">Docetaxel + Enzalutamide</text>
                        <text x="365" y="292" text-anchor="middle" font-size="9" fill="#555">Sequential: Chemo → Hormone</text>
                        
                        <!-- Option 4 -->
                        <rect x="265" y="316" width="200" height="54" fill="#f8f0ff" stroke="#9C27B0" stroke-width="2" rx="6"/>
                        <circle cx="280" cy="343" r="8" fill="#9C27B0"/>
                        <text x="280" y="347" text-anchor="middle" font-size="11" fill="#fff" font-weight="600">4</text>
                        <text x="365" y="334" text-anchor="middle" font-size="12" fill="#333" font-weight="600">Dose-Adapted Regimen</text>
                        <text x="365" y="350" text-anchor="middle" font-size="10" fill="#555">Personalized dose/schedule</text>
                        <text x="365" y="363" text-anchor="middle" font-size="9" fill="#555">Based on toxicity monitoring</text>
                    </g>
                    
                    <!-- Arrow -->
                    <path d="M 490 220 L 520 220" stroke="#1E64C8" stroke-width="4" marker-end="url(#arrow4)"/>
                    
                    <!-- Simulation & Optimization -->
                    <g>
                        <rect x="530" y="60" width="220" height="320" fill="#fff8f0" stroke="#FF9800" stroke-width="3" rx="10"/>
                        <text x="640" y="85" text-anchor="middle" font-size="15" fill="#FF9800" font-weight="700">Multi-Objective Optimization</text>
                        
                        <!-- Objective 1: Efficacy -->
                        <rect x="545" y="100" width="190" height="55" fill="#ffe8cc" stroke="#00AA00" stroke-width="2" rx="6"/>
                        <circle cx="560" cy="127.5" r="8" fill="#00AA00"/>
                        <path d="M 560 124 L 560 131" stroke="#fff" stroke-width="2"/>
                        <path d="M 557 127.5 L 563 127.5" stroke="#fff" stroke-width="2"/>
                        <text x="585" y="118" font-size="12" fill="#333" font-weight="600">Maximize Efficacy</text>
                        <text x="585" y="133" font-size="10" fill="#555">f₁(x) = Tumor reduction ↑</text>
                        <text x="585" y="146" font-size="9" fill="#666">Target: >60% reduction</text>
                        
                        <!-- Objective 2: Safety -->
                        <rect x="545" y="165" width="190" height="55" fill="#ffe8cc" stroke="#CC0000" stroke-width="2" rx="6"/>
                        <circle cx="560" cy="192.5" r="8" fill="#CC0000"/>
                        <path d="M 557 192.5 L 563 192.5" stroke="#fff" stroke-width="2"/>
                        <text x="585" y="183" font-size="12" fill="#333" font-weight="600">Minimize Toxicity</text>
                        <text x="585" y="198" font-size="10" fill="#555">f₂(x) = AE severity ↓</text>
                        <text x="585" y="211" font-size="9" fill="#666">Constraint: Grade ≤2</text>
                        
                        <!-- Objective 3: QoL -->
                        <rect x="545" y="230" width="190" height="55" fill="#ffe8cc" stroke="#0088CC" stroke-width="2" rx="6"/>
                        <circle cx="560" cy="257.5" r="8" fill="#0088CC"/>
                        <path d="M 557 260 L 560 257.5 L 563 260" stroke="#fff" stroke-width="2" fill="none"/>
                        <text x="585" y="248" font-size="12" fill="#333" font-weight="600">Maintain QoL</text>
                        <text x="585" y="263" font-size="10" fill="#555">f₃(x) = QoL index ↑</text>
                        <text x="585" y="276" font-size="9" fill="#666">Target: >75/100</text>
                        
                        <!-- Algorithm -->
                        <rect x="545" y="295" width="190" height="75" fill="#fff0cc" stroke="#9C27B0" stroke-width="2" rx="6"/>
                        <text x="640" y="313" text-anchor="middle" font-size="12" fill="#9C27B0" font-weight="600">Optimization Method</text>
                        <text x="640" y="330" text-anchor="middle" font-size="11" fill="#555">Multi-objective GA</text>
                        <text x="640" y="345" text-anchor="middle" font-size="10" fill="#666">Pareto frontier search</text>
                        <text x="640" y="360" text-anchor="middle" font-size="9" fill="#666">10,000 simulations per option</text>
                    </g>
                    
                    <!-- Arrow -->
                    <path d="M 760 220 L 790 220" stroke="#1E64C8" stroke-width="4" marker-end="url(#arrow4)"/>
                    
                    <!-- Optimal Strategy -->
                    <g>
                        <rect x="800" y="60" width="280" height="320" fill="#f8f0ff" stroke="#9C27B0" stroke-width="3" rx="10"/>
                        <text x="940" y="85" text-anchor="middle" font-size="15" fill="#9C27B0" font-weight="700">Recommended Treatment Plan</text>
                        
                        <!-- Best Option -->
                        <rect x="820" y="100" width="240" height="100" fill="#e8d4ff" stroke="#9C27B0" stroke-width="2" rx="8"/>
                        <path d="M 850 125 L 860 135 L 880 115" stroke="#00AA00" stroke-width="4" fill="none"/>
                        <text x="940" y="122" text-anchor="middle" font-size="13" fill="#9C27B0" font-weight="700">Optimal Strategy: Option 3</text>
                        <text x="940" y="142" text-anchor="middle" font-size="11" fill="#333">Modified Combination Therapy</text>
                        <text x="940" y="158" text-anchor="middle" font-size="10" fill="#555">• Docetaxel 60 mg/m² (80% dose)</text>
                        <text x="940" y="173" text-anchor="middle" font-size="10" fill="#555">• Q3W × 4 cycles (12 weeks)</text>
                        <text x="940" y="188" text-anchor="middle" font-size="10" fill="#555">• Then Enzalutamide 160mg daily</text>
                        
                        <!-- Predicted Outcomes -->
                        <rect x="820" y="210" width="240" height="100" fill="#ccf0cc" stroke="#00AA00" stroke-width="2" rx="8"/>
                        <text x="940" y="228" text-anchor="middle" font-size="13" fill="#00AA00" font-weight="700">Predicted Outcomes</text>
                        <text x="940" y="248" text-anchor="middle" font-size="11" fill="#555">Tumor reduction: 73% (95% CI: 68-78%)</text>
                        <text x="940" y="263" text-anchor="middle" font-size="11" fill="#555">PSA decline: >50% at 3 months</text>
                        <text x="940" y="278" text-anchor="middle" font-size="11" fill="#555">Grade 2 toxicity: 28% probability</text>
                        <text x="940" y="293" text-anchor="middle" font-size="11" fill="#555">QoL maintained: 82/100 avg</text>
                        
                        <!-- Confidence & Alternative -->
                        <rect x="820" y="320" width="115" height="50" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2" rx="6"/>
                        <text x="877.5" y="338" text-anchor="middle" font-size="11" fill="#1E64C8" font-weight="600">Confidence</text>
                        <text x="877.5" y="353" text-anchor="middle" font-size="10" fill="#555">87% success</text>
                        <text x="877.5" y="365" text-anchor="middle" font-size="9" fill="#666">10K sims</text>
                        
                        <rect x="945" y="320" width="115" height="50" fill="#fff8e8" stroke="#FF9800" stroke-width="2" rx="6"/>
                        <text x="1002.5" y="338" text-anchor="middle" font-size="11" fill="#FF9800" font-weight="600">Alternative</text>
                        <text x="1002.5" y="353" text-anchor="middle" font-size="10" fill="#555">Option 2</text>
                        <text x="1002.5" y="365" text-anchor="middle" font-size="9" fill="#666">if CHF worsens</text>
                    </g>
                    
                    <!-- Bottom note -->
                    <text x="550" y="405" text-anchor="middle" font-size="11" fill="#666" font-style="italic">Decision support: Clinician reviews recommendations with patient preferences</text>
                    
                    <defs>
                        <marker id="arrow4" markerWidth="12" markerHeight="12" refX="10" refY="4" orient="auto">
                            <path d="M0,0 L0,8 L12,4 z" fill="#1E64C8"/>
                        </marker>
                    </defs>
                </svg>
            </div>
            
            <div class="description-text">
                Treatment optimization leverages digital twins to identify the best therapeutic strategy for individual patients by simulating and comparing multiple treatment options across multiple competing objectives. This process goes beyond simple efficacy evaluation to balance effectiveness, safety, quality of life, treatment duration, cost, and patient preferences. The optimization employs advanced algorithms including multi-objective genetic algorithms, Pareto optimization, and reinforcement learning to explore vast treatment spaces and identify optimal strategies that account for patient-specific constraints, comorbidities, and individual goals.
            </div>
            
            <div class="key-points">
                <h4>Key Capabilities & Methods</h4>
                <ul>
                    <li><strong>Multi-Objective Optimization:</strong> Simultaneously optimizes multiple competing goals (efficacy, safety, QoL, cost) using Pareto frontier analysis to identify treatments offering best trade-offs across all objectives</li>
                    <li><strong>Dose and Schedule Optimization:</strong> Determines optimal drug dosing regimens, radiation fractionation schedules, timing of combination therapies, and treatment holidays using pharmacokinetic/pharmacodynamic modeling to maximize therapeutic window</li>
                    <li><strong>Adaptive Planning:</strong> Enables mid-treatment adjustments based on observed responses through Bayesian updating, allowing personalized adaptation as patient condition evolves (e.g., dose reduction for toxicity, dose intensification for poor response)</li>
                    <li><strong>Risk Stratification:</strong> Quantifies uncertainty in outcome predictions using Monte Carlo simulation and sensitivity analysis, identifying patient-specific risk factors that may affect treatment success</li>
                    <li><strong>Alternative Scenarios:</strong> Explores "what-if" scenarios (disease progression, treatment complications, comorbidity changes) to understand robustness and prepare contingency plans</li>
                    <li><strong>Constraint Handling:</strong> Incorporates hard constraints (maximum toxicity, budget limits) and soft preferences (minimize treatment visits, oral vs IV preference) into optimization</li>
                </ul>
            </div>
            
            <div class="example-box">
                <h4>Clinical Example: Precision Radiation Oncology for Non-Small Cell Lung Cancer</h4>
                <p>
                    For a 68-year-old lung cancer patient with a 4.8 cm right upper lobe tumor adjacent to critical structures, the digital twin integrates 4D-CT imaging showing tumor motion with respiration (1.2 cm superior-inferior), PET imaging indicating heterogeneous FDG uptake (SUVmax 12.8), pulmonary function tests (FEV1 68% predicted), and cardiac assessment showing prior MI with EF 45%. The optimization algorithm explores 50,000 different radiation delivery plans varying: beam angles (7-11 coplanar/non-coplanar), intensities (IMRT vs VMAT), fractionation (60Gy/30fx vs 70Gy/35fx vs SBRT 50Gy/5fx), and motion management strategies (free breathing vs breath-hold vs gating). The optimal plan delivers 70 Gy in 35 fractions using dual-arc VMAT with breath-hold, achieving: tumor D95% = 68 Gy (97% coverage), heart V30 = 18% (goal <30%), spinal cord Dmax = 42 Gy (limit <45 Gy), mean lung dose = 14 Gy (limit <20 Gy). Simulations predict 85% local control at 2 years (vs 78% with standard planning), 8% risk of grade 3+ pneumonitis (vs 23% standard), and 4% cardiac event risk at 5 years (vs 9% standard). The plan is successfully delivered with observed pneumonitis rate of 7.5% and 2-year local control of 83%, validating the digital twin predictions.
                </p>
            </div>
        </div>

        <!-- SECTION 5: Validation Approaches -->
        <div class="detailed-section">
            <div class="section-header">
                <div class="section-number">5</div>
                <div class="section-title">Validation Approaches: Comparing Predictions to Reality</div>
            </div>
            
            <div class="illustration-container">
                <svg width="1100" height="450" viewBox="0 0 1100 450">
                    <text x="550" y="30" text-anchor="middle" font-size="22" fill="#1E64C8" font-weight="700">Comprehensive Validation Framework</text>
                    
                    <!-- Validation Types (Top Row) -->
                    
                    <!-- Prospective Validation -->
                    <g>
                        <rect x="20" y="60" width="250" height="150" fill="#f0f8ff" stroke="#1E64C8" stroke-width="3" rx="10"/>
                        <text x="145" y="85" text-anchor="middle" font-size="14" fill="#1E64C8" font-weight="700">Prospective Validation</text>
                        <text x="145" y="102" text-anchor="middle" font-size="11" fill="#666">(Gold Standard)</text>
                        
                        <!-- Timeline -->
                        <line x1="40" y1="130" x2="250" y2="130" stroke="#1E64C8" stroke-width="3" marker-end="url(#arrow5)"/>
                        
                        <circle cx="60" cy="130" r="12" fill="#5088d4"/>
                        <text x="60" y="135" text-anchor="middle" font-size="11" fill="#fff" font-weight="600">1</text>
                        <text x="60" y="155" text-anchor="middle" font-size="10" fill="#333" font-weight="600">Predict</text>
                        <text x="60" y="167" text-anchor="middle" font-size="8" fill="#555">Before treatment</text>
                        
                        <circle cx="145" cy="130" r="12" fill="#2874d8"/>
                        <text x="145" y="135" text-anchor="middle" font-size="11" fill="#fff" font-weight="600">2</text>
                        <text x="145" y="155" text-anchor="middle" font-size="10" fill="#333" font-weight="600">Treat</text>
                        <text x="145" y="167" text-anchor="middle" font-size="8" fill="#555">Follow protocol</text>
                        
                        <circle cx="230" cy="130" r="12" fill="#1E64C8"/>
                        <text x="230" y="135" text-anchor="middle" font-size="11" fill="#fff" font-weight="600">3</text>
                        <text x="230" y="155" text-anchor="middle" font-size="10" fill="#333" font-weight="600">Compare</text>
                        <text x="230" y="167" text-anchor="middle" font-size="8" fill="#555">Outcome vs prediction</text>
                        
                        <rect x="40" y="180" width="210" height="20" fill="#e8f2ff" rx="4"/>
                        <text x="145" y="194" text-anchor="middle" font-size="10" fill="#333">✓ Unbiased • No data leakage</text>
                    </g>
                    
                    <!-- Retrospective Validation -->
                    <g>
                        <rect x="290" y="60" width="250" height="150" fill="#f0fff0" stroke="#00AA00" stroke-width="3" rx="10"/>
                        <text x="415" y="85" text-anchor="middle" font-size="14" fill="#00AA00" font-weight="700">Retrospective Validation</text>
                        <text x="415" y="102" text-anchor="middle" font-size="11" fill="#666">(Historical Analysis)</text>
                        
                        <!-- Timeline -->
                        <line x1="310" y1="130" x2="520" y2="130" stroke="#00AA00" stroke-width="3" marker-start="url(#arrowback)"/>
                        
                        <circle cx="500" cy="130" r="12" fill="#00AA00" opacity="0.5"/>
                        <text x="500" y="135" text-anchor="middle" font-size="11" fill="#fff" font-weight="600">1</text>
                        <text x="500" y="155" text-anchor="middle" font-size="10" fill="#333" font-weight="600">Outcome</text>
                        <text x="500" y="167" text-anchor="middle" font-size="8" fill="#555">Known (historical)</text>
                        
                        <circle cx="415" cy="130" r="12" fill="#00AA00" opacity="0.7"/>
                        <text x="415" y="135" text-anchor="middle" font-size="11" fill="#fff" font-weight="600">2</text>
                        <text x="415" y="155" text-anchor="middle" font-size="10" fill="#333" font-weight="600">Simulate</text>
                        <text x="415" y="167" text-anchor="middle" font-size="8" fill="#555">Past treatment</text>
                        
                        <circle cx="330" cy="130" r="12" fill="#00AA00"/>
                        <text x="330" y="135" text-anchor="middle" font-size="11" fill="#fff" font-weight="600">3</text>
                        <text x="330" y="155" text-anchor="middle" font-size="10" fill="#333" font-weight="600">Compare</text>
                        <text x="330" y="167" text-anchor="middle" font-size="8" fill="#555">Hindcast accuracy</text>
                        
                        <rect x="310" y="180" width="210" height="20" fill="#e8ffe8" rx="4"/>
                        <text x="415" y="194" text-anchor="middle" font-size="10" fill="#333">✓ Fast • Large datasets available</text>
                    </g>
                    
                    <!-- Cross-Validation -->
                    <g>
                        <rect x="560" y="60" width="250" height="150" fill="#fff8f0" stroke="#FF9800" stroke-width="3" rx="10"/>
                        <text x="685" y="85" text-anchor="middle" font-size="14" fill="#FF9800" font-weight="700">Cross-Validation</text>
                        <text x="685" y="102" text-anchor="middle" font-size="11" fill="#666">(Internal Validation)</text>
                        
                        <!-- K-fold visualization -->
                        <g transform="translate(590, 115)">
                            <rect x="0" y="0" width="35" height="30" fill="#0088CC" opacity="0.9"/>
                            <text x="17.5" y="18" text-anchor="middle" font-size="10" fill="#fff" font-weight="600">Test</text>
                            
                            <rect x="40" y="0" width="35" height="30" fill="#e8f2ff"/>
                            <text x="57.5" y="18" text-anchor="middle" font-size="9" fill="#333">Train</text>
                            
                            <rect x="80" y="0" width="35" height="30" fill="#e8f2ff"/>
                            <text x="97.5" y="18" text-anchor="middle" font-size="9" fill="#333">Train</text>
                            
                            <rect x="120" y="0" width="35" height="30" fill="#e8f2ff"/>
                            <text x="137.5" y="18" text-anchor="middle" font-size="9" fill="#333">Train</text>
                            
                            <rect x="160" y="0" width="35" height="30" fill="#e8f2ff"/>
                            <text x="177.5" y="18" text-anchor="middle" font-size="9" fill="#333">Train</text>
                        </g>
                        
                        <text x="685" y="163" text-anchor="middle" font-size="9" fill="#666">Fold 1 of 5-fold CV</text>
                        
                        <rect x="580" y="175" width="210" height="25" fill="#fff0e8" rx="4"/>
                        <text x="685" y="190" text-anchor="middle" font-size="10" fill="#333">✓ Prevents overfitting</text>
                        <text x="685" y="202" text-anchor="middle" font-size="9" fill="#666">Repeated 5 times, avg performance</text>
                    </g>
                    
                    <!-- External Validation -->
                    <g>
                        <rect x="830" y="60" width="250" height="150" fill="#f8f0ff" stroke="#9C27B0" stroke-width="3" rx="10"/>
                        <text x="955" y="85" text-anchor="middle" font-size="14" fill="#9C27B0" font-weight="700">External Validation</text>
                        <text x="955" y="102" text-anchor="middle" font-size="11" fill="#666">(Independent Dataset)</text>
                        
                        <!-- Multiple institutions -->
                        <g transform="translate(870, 115)">
                            <rect x="0" y="0" width="50" height="40" fill="#e8d4ff" stroke="#9C27B0" stroke-width="2" rx="4"/>
                            <path d="M 10 10 L 40 10 L 40 30 L 10 30 Z" fill="none" stroke="#9C27B0" stroke-width="1.5"/>
                            <text x="25" y="23" text-anchor="middle" font-size="8" fill="#9C27B0" font-weight="600">Site A</text>
                        </g>
                        
                        <g transform="translate(935, 115)">
                            <rect x="0" y="0" width="50" height="40" fill="#e8d4ff" stroke="#9C27B0" stroke-width="2" rx="4"/>
                            <path d="M 10 10 L 40 10 L 40 30 L 10 30 Z" fill="none" stroke="#9C27B0" stroke-width="1.5"/>
                            <text x="25" y="23" text-anchor="middle" font-size="8" fill="#9C27B0" font-weight="600">Site B</text>
                        </g>
                        
                        <g transform="translate(1000, 115)">
                            <rect x="0" y="0" width="50" height="40" fill="#e8d4ff" stroke="#9C27B0" stroke-width="2" rx="4"/>
                            <path d="M 10 10 L 40 10 L 40 30 L 10 30 Z" fill="none" stroke="#9C27B0" stroke-width="1.5"/>
                            <text x="25" y="23" text-anchor="middle" font-size="8" fill="#9C27B0" font-weight="600">Site C</text>
                        </g>
                        
                        <rect x="850" y="165" width="210" height="35" fill="#f0e8ff" rx="4"/>
                        <text x="955" y="180" text-anchor="middle" font-size="10" fill="#333">✓ Tests generalizability</text>
                        <text x="955" y="193" text-anchor="middle" font-size="9" fill="#666">Different populations/practices</text>
                    </g>
                    
                    <!-- Validation Metrics (Bottom Section) -->
                    <rect x="20" y="230" width="1060" height="200" fill="#f8fbff" stroke="#1E64C8" stroke-width="3" rx="10"/>
                    <text x="550" y="258" text-anchor="middle" font-size="16" fill="#1E64C8" font-weight="700">Performance Metrics & Statistical Tests</text>
                    
                    <!-- Regression Metrics -->
                    <g>
                        <rect x="40" y="275" width="250" height="140" fill="#fff" stroke="#0088CC" stroke-width="2" rx="8"/>
                        <text x="165" y="295" text-anchor="middle" font-size="13" fill="#0088CC" font-weight="700">Regression Metrics</text>
                        
                        <text x="50" y="318" font-size="11" fill="#333" font-weight="600">• Mean Absolute Error (MAE)</text>
                        <text x="60" y="333" font-size="9" fill="#666">Average |predicted - actual|</text>
                        
                        <text x="50" y="353" font-size="11" fill="#333" font-weight="600">• Root Mean Square Error (RMSE)</text>
                        <text x="60" y="368" font-size="9" fill="#666">√(mean squared errors)</text>
                        
                        <text x="50" y="388" font-size="11" fill="#333" font-weight="600">• R² Coefficient of Determination</text>
                        <text x="60" y="403" font-size="9" fill="#666">Proportion of variance explained</text>
                    </g>
                    
                    <!-- Classification Metrics -->
                    <g>
                        <rect x="305" y="275" width="250" height="140" fill="#fff" stroke="#00AA00" stroke-width="2" rx="8"/>
                        <text x="430" y="295" text-anchor="middle" font-size="13" fill="#00AA00" font-weight="700">Classification Metrics</text>
                        
                        <text x="315" y="318" font-size="11" fill="#333" font-weight="600">• Sensitivity & Specificity</text>
                        <text x="325" y="333" font-size="9" fill="#666">True positive & negative rates</text>
                        
                        <text x="315" y="353" font-size="11" fill="#333" font-weight="600">• ROC AUC & PR AUC</text>
                        <text x="325" y="368" font-size="9" fill="#666">Discrimination performance</text>
                        
                        <text x="315" y="388" font-size="11" fill="#333" font-weight="600">• F1 Score & Matthews Correlation</text>
                        <text x="325" y="403" font-size="9" fill="#666">Balanced accuracy measures</text>
                    </g>
                    
                    <!-- Calibration -->
                    <g>
                        <rect x="570" y="275" width="250" height="140" fill="#fff" stroke="#FF9800" stroke-width="2" rx="8"/>
                        <text x="695" y="295" text-anchor="middle" font-size="13" fill="#FF9800" font-weight="700">Calibration</text>
                        
                        <text x="580" y="318" font-size="11" fill="#333" font-weight="600">• Calibration Plots</text>
                        <text x="590" y="333" font-size="9" fill="#666">Predicted vs observed probabilities</text>
                        
                        <text x="580" y="353" font-size="11" fill="#333" font-weight="600">• Hosmer-Lemeshow Test</text>
                        <text x="590" y="368" font-size="9" fill="#666">Goodness-of-fit χ² test</text>
                        
                        <text x="580" y="388" font-size="11" fill="#333" font-weight="600">• Brier Score</text>
                        <text x="590" y="403" font-size="9" fill="#666">Mean squared error of probabilities</text>
                    </g>
                    
                    <!-- Clinical Utility -->
                    <g>
                        <rect x="835" y="275" width="230" height="140" fill="#fff" stroke="#9C27B0" stroke-width="2" rx="8"/>
                        <text x="950" y="295" text-anchor="middle" font-size="13" fill="#9C27B0" font-weight="700">Clinical Utility</text>
                        
                        <text x="845" y="318" font-size="11" fill="#333" font-weight="600">• Decision Curve Analysis</text>
                        <text x="855" y="333" font-size="9" fill="#666">Net benefit at risk thresholds</text>
                        
                        <text x="845" y="353" font-size="11" fill="#333" font-weight="600">• Impact on Outcomes</text>
                        <text x="855" y="368" font-size="9" fill="#666">Mortality, morbidity reduction</text>
                        
                        <text x="845" y="388" font-size="11" fill="#333" font-weight="600">• Cost-Effectiveness</text>
                        <text x="855" y="403" font-size="9" fill="#666">QALYs gained, ICER analysis</text>
                    </g>
                    
                    <defs>
                        <marker id="arrow5" markerWidth="12" markerHeight="12" refX="10" refY="4" orient="auto">
                            <path d="M0,0 L0,8 L12,4 z" fill="#1E64C8"/>
                        </marker>
                        <marker id="arrowback" markerWidth="12" markerHeight="12" refX="2" refY="4" orient="auto">
                            <path d="M12,0 L12,8 L0,4 z" fill="#00AA00"/>
                        </marker>
                    </defs>
                </svg>
            </div>
            
            <div class="description-text">
                Validation is the cornerstone of digital twin credibility, providing essential evidence that computational predictions reliably match real-world patient outcomes. Rigorous validation involves multiple complementary approaches including prospective testing on new patients (the gold standard), retrospective analysis of historical data (for rapid assessment), cross-validation within datasets (to prevent overfitting), and external validation across different institutions and populations (to ensure generalizability). Without thorough validation using multiple independent datasets and diverse patient populations, digital twins remain theoretical constructs rather than trusted clinical decision support tools worthy of regulatory approval and clinical adoption.
            </div>
            
            <div class="key-points">
                <h4>Key Validation Strategies</h4>
                <ul>
                    <li><strong>Prospective Clinical Validation:</strong> The gold standard where predictions are made before treatment and subsequently compared to actual observed outcomes in real patients receiving care. This approach eliminates data leakage and provides unbiased assessment of real-world performance</li>
                    <li><strong>Retrospective Analysis:</strong> Tests model performance on historical patient data where outcomes are already known, useful for initial validation and model refinement before expensive prospective testing. Enables rapid iteration and identification of systematic biases</li>
                    <li><strong>Cross-Validation:</strong> Systematically partitions data into training and testing sets (k-fold, leave-one-out, stratified sampling) to assess model generalization and prevent overfitting to specific patient cohorts or center-specific practices</li>
                    <li><strong>External Validation:</strong> Tests models on completely independent datasets from different institutions, geographic regions, time periods, or populations to ensure robustness and broad applicability beyond the development cohort</li>
                    <li><strong>Temporal Validation:</strong> Evaluates model performance on patients treated in different time periods to assess stability as medical practice evolves and treatment standards change</li>
                    <li><strong>Subgroup Analysis:</strong> Examines performance across clinically relevant subgroups (age, sex, disease stage, comorbidities) to identify populations where the model performs well or poorly</li>
                    <li><strong>Sensitivity Analysis:</strong> Evaluates how prediction accuracy varies with model assumptions, parameter uncertainty, and data quality to identify model vulnerabilities and required data quality thresholds</li>
                </ul>
            </div>
            
            <div class="example-box">
                <h4>Clinical Example: Sepsis Prediction System Multi-Phase Validation</h4>
                <p>
                    A digital twin for early sepsis prediction in ICU patients undergoes comprehensive multi-phase validation demonstrating clinical utility. <strong>Phase 1 (Retrospective):</strong> Analysis on 5,000 ICU admissions from a single center (2018-2020) shows 85% sensitivity and 92% specificity for predicting sepsis onset 6 hours before clinical recognition (SOFA score ≥2), with AUROC 0.91 (95% CI: 0.89-0.93) and calibration slope 1.02. <strong>Phase 2 (Cross-Validation):</strong> 5-fold stratified cross-validation confirms consistent performance across patient subgroups: medical ICU (AUROC 0.89), surgical ICU (0.92), age <65 (0.90), age ≥65 (0.91), APACHE II <15 (0.88), APACHE II ≥15 (0.93). <strong>Phase 3 (Prospective):</strong> Prospective validation in 500-patient cohort at same institution (2021) achieves 82% sensitivity, 88% specificity, with 15% false alarm rate (median 2.3 alarms/patient), and median advance warning time of 5.8 hours. <strong>Phase 4 (External Validation):</strong> Multi-center validation at three independent hospitals demonstrates maintained performance: Site A (academic, n=800): AUROC 0.87, Site B (community, n=650): AUROC 0.89, Site C (international, n=420): AUROC 0.91. <strong>Phase 5 (Clinical Utility):</strong> Randomized controlled trial (n=1,200, 600 per arm) shows the system enables 3.2 hours earlier treatment initiation (antibiotics, fluids, vasopressors), reducing ICU mortality from 18.3% to 13.1% (p=0.002, NNT=19), decreasing ICU length of stay from 8.4 to 7.1 days (p=0.01), and estimated cost savings of $4,200 per patient. The comprehensive validation across multiple phases, institutions, and patient populations, combined with demonstrated clinical impact in an RCT, provides strong evidence supporting clinical adoption and regulatory approval.
                </p>
            </div>
        </div>

    </div>
</body>
</html>